Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:fluoranthene
go back to main search page
Accession:CHEBI:33083 term browser browse the term
Definition:An ortho- and peri-fused polycyclic arene consisting of a naphthalene and benzene unit connected by a five-membered ring.
Synonyms:related_synonym: Formula=C16H10;   InChI=1S/C16H10/c1-2-8-13-12(7-1)14-9-3-5-11-6-4-10-15(13)16(11)14/h1-10H;   InChIKey=GVEPBJHOBDJJJI-UHFFFAOYSA-N;   SMILES=c1ccc-2c(c1)-c1cccc3cccc-2c13;   benzo[jk]fluorene
 xref: Beilstein:1907918;   CAS:206-44-0;   Gmelin:262216;   KEGG:C19425
 xref_mesh: MESH:C007738
 xref: MetaCyc:CPD-15564;   PMID:15278918;   PMID:17258277;   PMID:23943046;   PMID:24151025;   Reaxys:1907918;   Wikipedia:Fluoranthene


show annotations for term's descendants           Sort by:
fluoranthene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2M alpha-2-macroglobulin multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of A2M mRNA CTD PMID:17690111 NCBI chr12:9,067,708...9,116,229
Ensembl chr12:9,067,664...9,116,229 		JBrowse link
G AACS acetoacetyl-CoA synthetase decreases expression ISO fluoranthene results in decreased expression of AACS mRNA CTD PMID:28329830 NCBI chr12:125,065,435...125,143,316
Ensembl chr12:125,065,434...125,143,333 		JBrowse link
G ABCD1 ATP binding cassette subfamily D member 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ABCD1 mRNA CTD PMID:28329830 NCBI chr  X:153,724,856...153,744,755
Ensembl chr  X:153,724,856...153,744,755 		JBrowse link
G ABCD3 ATP binding cassette subfamily D member 3 multiple interactions ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ABCD3 mRNA CTD PMID:18711122 NCBI chr 1:94,385,131...94,518,663
Ensembl chr 1:94,418,389...94,518,666 		JBrowse link
G ABL2 ABL proto-oncogene 2, non-receptor tyrosine kinase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ABL2 mRNA CTD PMID:28329830 NCBI chr 1:179,099,330...179,229,677
Ensembl chr 1:179,099,330...179,229,684 		JBrowse link
G ABTB2 ankyrin repeat and BTB domain containing 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ABTB2 mRNA CTD PMID:28329830 NCBI chr11:34,150,987...34,358,010
Ensembl chr11:34,150,987...34,358,010 		JBrowse link
G ACAD10 acyl-CoA dehydrogenase family member 10 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ACAD10 mRNA CTD PMID:28329830 NCBI chr12:111,686,053...111,757,099
Ensembl chr12:111,686,053...111,757,107 		JBrowse link
G ACBD3 acyl-CoA binding domain containing 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ACBD3 mRNA CTD PMID:28329830 NCBI chr 1:226,144,679...226,186,741
Ensembl chr 1:226,144,679...226,186,741 		JBrowse link
G ACOT2 acyl-CoA thioesterase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ACOT2 mRNA CTD PMID:28329830 NCBI chr14:73,567,620...73,575,658
Ensembl chr14:73,567,620...73,575,658 		JBrowse link
G ACOX2 acyl-CoA oxidase 2 multiple interactions ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ACOX2 mRNA CTD PMID:18711122 NCBI chr 3:58,505,136...58,537,190
Ensembl chr 3:58,505,136...58,537,283 		JBrowse link
G ACSL3 acyl-CoA synthetase long chain family member 3 decreases expression ISO fluoranthene results in decreased expression of ACSL3 mRNA CTD PMID:28329830 NCBI chr 2:222,861,036...222,944,639
Ensembl chr 2:222,860,942...222,944,639 		JBrowse link
G ACSL4 acyl-CoA synthetase long chain family member 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ACSL4 mRNA CTD PMID:28329830 NCBI chr  X:109,641,335...109,733,257
Ensembl chr  X:109,624,244...109,733,403 		JBrowse link
G ACY3 aminoacylase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ACY3 mRNA CTD PMID:28329830 NCBI chr11:67,642,555...67,650,730
Ensembl chr11:67,642,555...67,650,730 		JBrowse link
G ADAMTS1 ADAM metallopeptidase with thrombospondin type 1 motif 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ADAMTS1 mRNA CTD PMID:28329830 NCBI chr21:26,835,755...26,845,409
Ensembl chr21:26,835,755...26,845,409 		JBrowse link
G ADAMTS4 ADAM metallopeptidase with thrombospondin type 1 motif 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ADAMTS4 mRNA CTD PMID:28329830 NCBI chr 1:161,184,302...161,199,054
Ensembl chr 1:161,184,302...161,199,054 		JBrowse link
G ADAMTS5 ADAM metallopeptidase with thrombospondin type 1 motif 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ADAMTS5 mRNA CTD PMID:28329830 NCBI chr21:26,917,922...26,967,088
Ensembl chr21:26,917,922...26,967,088 		JBrowse link
G ADGRD1 adhesion G protein-coupled receptor D1 multiple interactions
decreases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ADGRD1 mRNA
fluoranthene results in decreased expression of ADGRD1 mRNA		 CTD PMID:28329830 NCBI chr12:130,953,907...131,141,469
Ensembl chr12:130,953,907...131,141,469 		JBrowse link
G ADH1C alcohol dehydrogenase 1C (class I), gamma polypeptide multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ADH1 mRNA CTD PMID:28329830 NCBI chr 4:99,336,497...99,352,746
Ensembl chr 4:99,336,497...99,352,746 		JBrowse link
G ADH7 alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide multiple interactions
increases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ADH7 mRNA
fluoranthene results in increased expression of ADH7 mRNA		 CTD PMID:28329830 NCBI chr 4:99,412,263...99,435,342
Ensembl chr 4:99,412,261...99,435,510 		JBrowse link
G ADI1 acireductone dioxygenase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ADI1 mRNA CTD PMID:28329830 NCBI chr 2:3,497,366...3,519,531
Ensembl chr 2:3,497,366...3,519,531 		JBrowse link
G AFF1 ALF transcription elongation factor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of AFF1 mRNA CTD PMID:28329830 NCBI chr 4:86,935,011...87,141,039
Ensembl chr 4:86,935,002...87,141,039 		JBrowse link
G AFG2A AFG2 AAA ATPase homolog A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of AFG2A mRNA CTD PMID:28329830 NCBI chr 4:122,923,078...123,319,433
Ensembl chr 4:122,923,070...123,319,433 		JBrowse link
G AFTPH aftiphilin multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of AFTPH mRNA CTD PMID:28329830 NCBI chr 2:64,524,328...64,593,005
Ensembl chr 2:64,524,299...64,593,005 		JBrowse link
G AHR aryl hydrocarbon receptor multiple interactions
increases activity		 EXP
ISO		 [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [indeno(1,2,3-cd)pyrene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene] promotes the reaction [pyrene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with pyrene] promotes the reaction [fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [chrysene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benzo(k)fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benzo(j)fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [Benzo(a)pyrene results in increased activity of AHR protein]; [Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benz(a)anthracene results in increased activity of AHR protein]; [fluoranthene co-treated with Benzo(a)pyrene] results in increased activity of AHR protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein]; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein]; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein]; fluoranthene promotes the reaction [pyrene results in increased activity of AHR protein]; pyrene promotes the reaction [fluoranthene results in increased activity of AHR protein]
fluoranthene analog results in increased activity of AHR protein		 CTD PMID:17665671 PMID:25500124 PMID:28710019 PMID:30980910 NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152 		JBrowse link
G AHRR aryl hydrocarbon receptor repressor increases expression
multiple interactions		 ISO
EXP		 fluoranthene results in increased expression of AHRR mRNA
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHRR protein; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein]; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein]
TNF protein inhibits the reaction [fluoranthene results in increased expression of AHRR mRNA]		 CTD PMID:25268939 PMID:28710019 PMID:30980910 NCBI chr 5:321,714...438,285
Ensembl chr 5:321,714...438,291 		JBrowse link
G AK4 adenylate kinase 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of AK4 mRNA CTD PMID:28329830 NCBI chr 1:65,147,552...65,232,145
Ensembl chr 1:65,147,549...65,232,145 		JBrowse link
G AKR1B1 aldo-keto reductase family 1 member B multiple interactions EXP
ISO		 [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of AKR1B1 mRNA
[1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of AKR1B1 mRNA		 CTD PMID:17690111 PMID:18711122 NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284 		JBrowse link
G ALDH3A1 aldehyde dehydrogenase 3 family member A1 multiple interactions
increases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ALDH3A1 mRNA
fluoranthene results in increased expression of ALDH3A1 mRNA		 CTD PMID:28329830 NCBI chr17:19,737,984...19,748,298
Ensembl chr17:19,737,984...19,748,943 		JBrowse link
G ALDOB aldolase, fructose-bisphosphate B multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of ALDOB mRNA CTD PMID:17690111 NCBI chr 9:101,420,560...101,435,774
Ensembl chr 9:101,420,560...101,449,664 		JBrowse link
G ALKBH7 alkB homolog 7 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ALKBH7 mRNA CTD PMID:28329830 NCBI chr19:6,372,794...6,375,250
Ensembl chr19:6,372,794...6,375,250 		JBrowse link
G AMPD3 adenosine monophosphate deaminase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of AMPD3 mRNA CTD PMID:28329830 NCBI chr11:10,450,388...10,507,579
Ensembl chr11:10,308,313...10,507,579 		JBrowse link
G ANGPTL4 angiopoietin like 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ANGPTL4 mRNA CTD PMID:28329830 NCBI chr19:8,364,155...8,374,370
Ensembl chr19:8,363,289...8,374,370 		JBrowse link
G ANKRD11 ankyrin repeat domain containing 11 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ANKRD11 mRNA CTD PMID:28329830 NCBI chr16:89,267,630...89,490,561
Ensembl chr16:89,267,630...89,490,561 		JBrowse link
G ANKRD37 ankyrin repeat domain 37 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ANKRD37 mRNA CTD PMID:28329830 NCBI chr 4:185,396,841...185,400,723
Ensembl chr 4:185,396,021...185,400,628 		JBrowse link
G ANTXR2 ANTXR cell adhesion molecule 2 multiple interactions
increases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ANTXR2 mRNA
fluoranthene results in increased expression of ANTXR2 mRNA		 CTD PMID:28329830 NCBI chr 4:79,901,146...80,073,472
Ensembl chr 4:79,901,146...80,125,454 		JBrowse link
G AP1S1 adaptor related protein complex 1 subunit sigma 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of AP1S1 mRNA CTD PMID:28329830 NCBI chr 7:101,154,476...101,161,276
Ensembl chr 7:101,154,456...101,161,596 		JBrowse link
G APLN apelin multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of APLN mRNA CTD PMID:28329830 NCBI chr  X:129,645,259...129,654,956
Ensembl chr  X:129,645,259...129,654,956 		JBrowse link
G APOBR apolipoprotein B receptor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of APOBR mRNA CTD PMID:28329830 NCBI chr16:28,494,643...28,498,964
Ensembl chr16:28,494,643...28,498,964 		JBrowse link
G APOC3 apolipoprotein C3 multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of APOC3 mRNA CTD PMID:17690111 NCBI chr11:116,829,907...116,833,072
Ensembl chr11:116,829,706...116,833,072 		JBrowse link
G AR androgen receptor multiple interactions EXP [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein]; fluoranthene binds to and results in decreased activity of AR protein; fluoranthene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; fluoranthene inhibits the reaction [Metribolone results in increased activity of AR protein] CTD PMID:10771140 PMID:18324785 PMID:30980910 PMID:33049310 NCBI chr  X:67,544,021...67,730,619
Ensembl chr  X:67,544,021...67,730,619 		JBrowse link
G ARAP2 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ARAP2 mRNA CTD PMID:28329830 NCBI chr 4:36,005,404...36,244,784
Ensembl chr 4:35,948,221...36,244,514 		JBrowse link
G ARFGAP1 ADP ribosylation factor GTPase activating protein 1 multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of ARFGAP1 mRNA CTD PMID:18711122 NCBI chr20:63,272,813...63,289,790
Ensembl chr20:63,272,785...63,289,790 		JBrowse link
G ARHGEF2 Rho/Rac guanine nucleotide exchange factor 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ARHGEF2 mRNA CTD PMID:28329830 NCBI chr 1:155,946,854...155,979,617
Ensembl chr 1:155,946,851...156,007,070 		JBrowse link
G ARHGEF28 Rho guanine nucleotide exchange factor 28 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ARHGEF28 mRNA CTD PMID:28329830 NCBI chr 5:73,626,196...73,941,990
Ensembl chr 5:73,626,158...73,941,993 		JBrowse link
G ARID5A AT-rich interaction domain 5A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ARID5A mRNA CTD PMID:28329830 NCBI chr 2:96,536,752...96,552,638
Ensembl chr 2:96,536,743...96,552,634 		JBrowse link
G ARL2BP ADP ribosylation factor like GTPase 2 binding protein multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ARL2BP mRNA CTD PMID:28329830 NCBI chr16:57,245,259...57,253,635
Ensembl chr16:57,245,259...57,253,635 		JBrowse link
G ARL5B ADP ribosylation factor like GTPase 5B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ARL5B mRNA CTD PMID:28329830 NCBI chr10:18,659,431...18,681,639
Ensembl chr10:18,659,431...18,681,639 		JBrowse link
G ARNT aryl hydrocarbon receptor nuclear translocator multiple interactions EXP [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of ARNT protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of ARNT mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ARNT mRNA CTD PMID:28710019 NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,809,713...150,876,708 		JBrowse link
G ARRDC4 arrestin domain containing 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ARRDC4 mRNA CTD PMID:28329830 NCBI chr15:97,960,703...97,973,833
Ensembl chr15:97,960,703...97,973,833 		JBrowse link
G ARSJ arylsulfatase family member J multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ARSJ mRNA CTD PMID:28329830 NCBI chr 4:113,900,284...113,979,647
Ensembl chr 4:113,900,284...113,979,727 		JBrowse link
G ASAP2 ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ASAP2 mRNA CTD PMID:28329830 NCBI chr 2:9,206,812...9,405,678
Ensembl chr 2:9,206,765...9,405,683 		JBrowse link
G ASCC3 activating signal cointegrator 1 complex subunit 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ASCC3 mRNA CTD PMID:28329830 NCBI chr 6:100,508,194...100,881,329
Ensembl chr 6:100,508,194...100,881,372 		JBrowse link
G ATF3 activating transcription factor 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ATF3 mRNA CTD PMID:28329830 NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777 		JBrowse link
G ATF4 activating transcription factor 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ATF4 mRNA CTD PMID:28329830 NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,683 		JBrowse link
G ATOH8 atonal bHLH transcription factor 8 increases expression ISO fluoranthene results in increased expression of ATOH8 mRNA CTD PMID:28329830 NCBI chr 2:85,753,991...85,791,383
Ensembl chr 2:85,751,344...85,791,383 		JBrowse link
G ATOX1 antioxidant 1 copper chaperone multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ATOX1 mRNA CTD PMID:28329830 NCBI chr 5:151,742,822...151,758,631
Ensembl chr 5:151,742,316...151,772,532 		JBrowse link
G ATP23 ATP23 metallopeptidase and ATP synthase assembly factor homolog multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ATP23 mRNA CTD PMID:28329830 NCBI chr12:57,941,567...57,959,148
Ensembl chr12:57,906,039...57,959,148 		JBrowse link
G AVL9 AVL9 cell migration associated multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of AVL9 mRNA CTD PMID:28329830 NCBI chr 7:32,495,489...32,588,726
Ensembl chr 7:32,495,426...32,588,726 		JBrowse link
G AXIN2 axin 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of AXIN2 mRNA CTD PMID:28329830 NCBI chr17:65,528,563...65,561,648
Ensembl chr17:65,528,563...65,561,648 		JBrowse link
G BAX BCL2 associated X, apoptosis regulator multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of BAX mRNA CTD PMID:17690111 NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798 		JBrowse link
G BBS7 Bardet-Biedl syndrome 7 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of BBS7 mRNA CTD PMID:28329830 NCBI chr 4:121,824,329...121,870,474
Ensembl chr 4:121,824,329...121,870,487 		JBrowse link
G BCAR3 BCAR3 adaptor protein, NSP family member multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BCAR3 mRNA CTD PMID:28329830 NCBI chr 1:93,561,741...93,848,151
Ensembl chr 1:93,561,741...93,847,150 		JBrowse link
G BCL10 BCL10 immune signaling adaptor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BCL10 mRNA CTD PMID:28329830 NCBI chr 1:85,265,776...85,276,632
Ensembl chr 1:85,265,776...85,276,632 		JBrowse link
G BCL3 BCL3 transcription coactivator multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BCL3 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of BCL3 mRNA] CTD PMID:28329830 NCBI chr19:44,747,705...44,760,044
Ensembl chr19:44,747,705...44,760,044 		JBrowse link
G BCL6 BCL6 transcription repressor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BCL6 mRNA CTD PMID:28329830 NCBI chr 3:187,721,377...187,745,468
Ensembl chr 3:187,721,377...187,745,725 		JBrowse link
G BCL9 BCL9 transcription coactivator multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of BCL9 mRNA CTD PMID:28329830 NCBI chr 1:147,541,501...147,626,216
Ensembl chr 1:147,541,501...147,626,216 		JBrowse link
G BDNF brain derived neurotrophic factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BDNF mRNA CTD PMID:28329830 NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058 		JBrowse link
G BIRC3 baculoviral IAP repeat containing 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BIRC3 mRNA CTD PMID:28329830 NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403 		JBrowse link
G BLZF1 basic leucine zipper nuclear factor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BLZF1 mRNA CTD PMID:28329830 NCBI chr 1:169,368,195...169,396,575
Ensembl chr 1:169,367,970...169,396,540 		JBrowse link
G BMP2K BMP2 inducible kinase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BMP2K mRNA CTD PMID:28329830 NCBI chr 4:78,776,350...78,916,365
Ensembl chr 4:78,776,342...78,916,365 		JBrowse link
G BNIP3 BCL2 interacting protein 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of BNIP3 mRNA CTD PMID:28329830 NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967 		JBrowse link
G BRD1 bromodomain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BRD1 mRNA CTD PMID:28329830 NCBI chr22:49,773,278...49,827,873
Ensembl chr22:49,773,283...49,827,873 		JBrowse link
G BTAF1 B-TFIID TATA-box binding protein associated factor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BTAF1 mRNA CTD PMID:28329830 NCBI chr10:91,923,770...92,031,437
Ensembl chr10:91,923,770...92,031,437 		JBrowse link
G BTG1 BTG anti-proliferation factor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BTG1 mRNA CTD PMID:28329830 NCBI chr12:92,140,278...92,145,846
Ensembl chr12:92,140,278...92,145,846 		JBrowse link
G BTG2 BTG anti-proliferation factor 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of BTG2 mRNA CTD PMID:28329830 NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602 		JBrowse link
G C1RL complement C1r subcomponent like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of C1RL mRNA CTD PMID:28329830 NCBI chr12:7,094,554...7,109,214
Ensembl chr12:7,089,587...7,109,238 		JBrowse link
G C21orf91 chromosome 21 open reading frame 91 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of D16ERTD472E mRNA CTD PMID:28329830 NCBI chr21:17,788,974...17,819,356
Ensembl chr21:17,788,974...17,819,386 		JBrowse link
G CALM3 calmodulin 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CALM3 mRNA CTD PMID:28329830 NCBI chr19:46,601,074...46,610,782
Ensembl chr19:46,601,074...46,610,782 		JBrowse link
G CAPS calcyphosine multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TNFRSF23 mRNA CTD PMID:28329830 NCBI chr19:5,914,254...5,916,211
Ensembl chr19:5,912,339...5,916,211 		JBrowse link
G CARS1 cysteinyl-tRNA synthetase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CARS1 mRNA CTD PMID:28329830 NCBI chr11:3,000,929...3,057,423
Ensembl chr11:3,000,922...3,057,613 		JBrowse link
G CASP4 caspase 4 increases expression
multiple interactions		 ISO fluoranthene results in increased expression of CASP4 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of CASP4 mRNA		 CTD PMID:28329830 NCBI chr11:104,942,866...104,968,574
Ensembl chr11:104,942,866...104,969,366 		JBrowse link
G CASP6 caspase 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CASP6 mRNA CTD PMID:28329830 NCBI chr 4:109,664,388...109,709,767
Ensembl chr 4:109,688,622...109,703,583 		JBrowse link
G CAVIN1 caveolae associated protein 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CAVIN1 mRNA CTD PMID:28329830 NCBI chr17:42,402,449...42,423,256
Ensembl chr17:42,402,449...42,423,256 		JBrowse link
G CAVIN3 caveolae associated protein 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CAVIN3 mRNA CTD PMID:28329830 NCBI chr11:6,318,946...6,320,501
Ensembl chr11:6,318,946...6,320,532 		JBrowse link
G CBY1 chibby 1, beta catenin antagonist multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CBY1 mRNA CTD PMID:28329830 NCBI chr22:38,656,638...38,673,850
Ensembl chr22:38,656,636...38,673,854 		JBrowse link
G CCDC186 coiled-coil domain containing 186 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CCDC186 mRNA CTD PMID:28329830 NCBI chr10:114,120,862...114,174,220
Ensembl chr10:114,120,862...114,174,232 		JBrowse link
G CCL2 C-C motif chemokine ligand 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CCL2 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of CCL2 mRNA] CTD PMID:28329830 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208 		JBrowse link
G CCL7 C-C motif chemokine ligand 7 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CCL7 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of CCL7 mRNA] CTD PMID:28329830 NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242 		JBrowse link
G CCN1 cellular communication network factor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CCN1 mRNA CTD PMID:28329830 NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589 		JBrowse link
G CCNA2 cyclin A2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CCNA2 mRNA CTD PMID:28329830 NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883 		JBrowse link
G CCND1 cyclin D1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CCND1 mRNA CTD PMID:28329830 NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474 		JBrowse link
G CCNE2 cyclin E2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CCNE2 mRNA CTD PMID:28329830 NCBI chr 8:94,880,224...94,896,693
Ensembl chr 8:94,879,770...94,896,678 		JBrowse link
G CCNL1 cyclin L1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CCNL1 mRNA CTD PMID:28329830 NCBI chr 3:157,143,121...157,160,147
Ensembl chr 3:157,146,508...157,160,760 		JBrowse link
G CCR7 C-C motif chemokine receptor 7 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CCR7 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of CCR7 mRNA] CTD PMID:28329830 NCBI chr17:40,553,769...40,565,472
Ensembl chr17:40,553,769...40,565,472 		JBrowse link
G CCSER1 coiled-coil serine rich protein 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CCSER1 mRNA CTD PMID:28329830 NCBI chr 4:90,127,394...91,605,295
Ensembl chr 4:90,127,394...91,605,295 		JBrowse link
G CDC42EP3 CDC42 effector protein 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CDC42EP3 mRNA CTD PMID:28329830 NCBI chr 2:37,641,944...37,672,949
Ensembl chr 2:37,641,882...37,738,468 		JBrowse link
G CDC6 cell division cycle 6 multiple interactions
decreases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CDC6 mRNA
fluoranthene results in decreased expression of CDC6 mRNA		 CTD PMID:28329830 NCBI chr17:40,287,879...40,304,657
Ensembl chr17:40,287,879...40,304,657 		JBrowse link
G CDH1 cadherin 1 multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of CDH1 mRNA CTD PMID:17690111 NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537 		JBrowse link
G CDH17 cadherin 17 multiple interactions ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CDH17 mRNA CTD PMID:18711122 NCBI chr 8:94,127,162...94,217,278
Ensembl chr 8:94,127,162...94,217,303 		JBrowse link
G CDIPT CDP-diacylglycerol--inositol 3-phosphatidyltransferase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CDIPT mRNA CTD PMID:28329830 NCBI chr16:29,858,357...29,863,226
Ensembl chr16:29,858,357...29,863,414 		JBrowse link
G CDK18 cyclin dependent kinase 18 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CDK18 mRNA CTD PMID:28329830 NCBI chr 1:205,504,669...205,532,790
Ensembl chr 1:205,504,596...205,532,793 		JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A multiple interactions EXP
ISO		 [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of CDKN1A mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of CDKN1A mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of CDKN1A mRNA]		 CTD PMID:17690111 PMID:28329830 NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337 		JBrowse link
G CDKN2C cyclin dependent kinase inhibitor 2C multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CDKN2C mRNA CTD PMID:28329830 NCBI chr 1:50,968,706...50,974,634
Ensembl chr 1:50,960,745...50,974,634 		JBrowse link
G CDON cell adhesion associated, oncogene regulated decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of CDON mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of CDON mRNA		 CTD PMID:28329830 NCBI chr11:125,956,821...126,063,352
Ensembl chr11:125,955,796...126,063,335 		JBrowse link
G CDR2 cerebellar degeneration related protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CDR2 mRNA CTD PMID:28329830 NCBI chr16:22,345,936...22,374,619
Ensembl chr16:22,345,936...22,437,165 		JBrowse link
G CEBPB CCAAT enhancer binding protein beta multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CEBPB mRNA CTD PMID:28329830 NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,830...50,192,668 		JBrowse link
G CEBPD CCAAT enhancer binding protein delta multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CEBPD mRNA CTD PMID:28329830 NCBI chr 8:47,736,913...47,738,164
Ensembl chr 8:47,736,913...47,738,164 		JBrowse link
G CEBPG CCAAT enhancer binding protein gamma multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CEBPG mRNA CTD PMID:28329830 NCBI chr19:33,373,709...33,382,686
Ensembl chr19:33,373,685...33,382,686 		JBrowse link
G CEBPZ CCAAT enhancer binding protein zeta multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CEBPZ mRNA CTD PMID:28329830 NCBI chr 2:37,201,612...37,231,596
Ensembl chr 2:37,201,612...37,231,596 		JBrowse link
G CEBPZOS CEBPZ opposite strand multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CEBPZOS mRNA CTD PMID:28329830 NCBI chr 2:37,196,496...37,216,193
Ensembl chr 2:37,196,488...37,216,193 		JBrowse link
G CEMIP cell migration inducing hyaluronidase 1 decreases expression ISO fluoranthene results in decreased expression of CEMIP mRNA CTD PMID:28329830 NCBI chr15:80,779,370...80,951,771
Ensembl chr15:80,779,343...80,951,776 		JBrowse link
G CENPX centromere protein X multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CENPX mRNA CTD PMID:28329830 NCBI chr17:82,018,703...82,022,878
Ensembl chr17:82,018,702...82,024,107 		JBrowse link
G CEP85L centrosomal protein 85 like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CEP85L mRNA CTD PMID:28329830 NCBI chr 6:118,460,772...118,710,089
Ensembl chr 6:118,460,772...118,710,075 		JBrowse link
G CHAC1 ChaC glutathione specific gamma-glutamylcyclotransferase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CHAC1 mRNA CTD PMID:28329830 NCBI chr15:40,953,471...40,956,512
Ensembl chr15:40,952,962...40,956,512 		JBrowse link
G CHD2 chromodomain helicase DNA binding protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CHD2 mRNA CTD PMID:28329830 NCBI chr15:92,900,324...93,027,996
Ensembl chr15:92,886,203...93,027,996 		JBrowse link
G CHEK2 checkpoint kinase 2 multiple interactions
increases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CHEK2 mRNA
fluoranthene results in increased expression of CHEK2 mRNA		 CTD PMID:28329830 NCBI chr22:28,687,743...28,741,834
Ensembl chr22:28,687,743...28,742,422 		JBrowse link
G CHIC2 cysteine rich hydrophobic domain 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CHIC2 mRNA CTD PMID:28329830 NCBI chr 4:54,009,789...54,091,879
Ensembl chr 4:54,009,789...54,064,605 		JBrowse link
G CHKA choline kinase alpha multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CHKA mRNA CTD PMID:28329830 NCBI chr11:68,052,859...68,121,388
Ensembl chr11:68,052,859...68,121,444 		JBrowse link
G CHST12 carbohydrate sulfotransferase 12 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CHST12 mRNA CTD PMID:28329830 NCBI chr 7:2,403,448...2,448,484
Ensembl chr 7:2,403,588...2,448,484 		JBrowse link
G CLDN25 claudin 25 multiple interactions
increases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CLDN25 mRNA
fluoranthene results in increased expression of CLDN25 mRNA		 CTD PMID:28329830 NCBI chr11:113,779,796...113,780,485
Ensembl chr11:113,779,796...113,780,485 		JBrowse link
G CLDN7 claudin 7 multiple interactions ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CLDN7 mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of CLDN7 mRNA CTD PMID:18711122 NCBI chr17:7,259,903...7,263,213
Ensembl chr17:7,259,903...7,263,983 		JBrowse link
G CLEC2D C-type lectin domain family 2 member D multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CLEC2D mRNA CTD PMID:28329830 NCBI chr12:9,669,713...9,699,553
Ensembl chr12:9,664,969...9,699,553 		JBrowse link
G CLK1 CDC like kinase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CLK1 mRNA CTD PMID:28329830 NCBI chr 2:200,853,009...200,864,658
Ensembl chr 2:200,853,009...200,864,691 		JBrowse link
G CLK4 CDC like kinase 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CLK4 mRNA CTD PMID:28329830 NCBI chr 5:178,602,664...178,627,050
Ensembl chr 5:178,602,664...178,630,615 		JBrowse link
G CMTR2 cap methyltransferase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CMTR2 mRNA CTD PMID:28329830 NCBI chr16:71,281,392...71,289,722
Ensembl chr16:71,281,389...71,289,715 		JBrowse link
G CNNM4 cyclin and CBS domain divalent metal cation transport mediator 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CNNM4 mRNA CTD PMID:28329830 NCBI chr 2:96,760,902...96,811,874
Ensembl chr 2:96,760,902...96,811,874 		JBrowse link
G COMT catechol-O-methyltransferase multiple interactions EXP [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of COMT mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of and affects the activity of COMT protein CTD PMID:28710019 NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975 		JBrowse link
G COPRS coordinator of PRMT5 and differentiation stimulator multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of COPRS mRNA CTD PMID:28329830 NCBI chr17:31,851,871...31,859,244
Ensembl chr17:31,851,871...31,859,291 		JBrowse link
G COQ10B coenzyme Q10B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of COQ10B mRNA CTD PMID:28329830 NCBI chr 2:197,453,552...197,475,310
Ensembl chr 2:197,453,493...197,475,310 		JBrowse link
G COX20 cytochrome c oxidase assembly factor COX20 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of COX20 mRNA CTD PMID:28329830 NCBI chr 1:244,835,306...244,845,063
Ensembl chr 1:244,835,616...244,845,057 		JBrowse link
G CP ceruloplasmin multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of CP mRNA CTD PMID:17690111 NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829 		JBrowse link
G CPEB4 cytoplasmic polyadenylation element binding protein 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CPEB4 mRNA CTD PMID:28329830 NCBI chr 5:173,888,349...173,961,980
Ensembl chr 5:173,888,349...173,961,980 		JBrowse link
G CPOX coproporphyrinogen oxidase multiple interactions
increases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CPOX mRNA
fluoranthene results in increased expression of CPOX mRNA		 CTD PMID:28329830 NCBI chr 3:98,570,488...98,593,611
Ensembl chr 3:98,579,446...98,593,648 		JBrowse link
G CPT2 carnitine palmitoyltransferase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CPT2 mRNA CTD PMID:28329830 NCBI chr 1:53,196,824...53,214,197
Ensembl chr 1:53,196,792...53,214,197 		JBrowse link
G CREB5 cAMP responsive element binding protein 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CREB5 mRNA CTD PMID:28329830 NCBI chr 7:28,299,321...28,825,894
Ensembl chr 7:28,299,321...28,825,894 		JBrowse link
G CREBRF CREB3 regulatory factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CREBRF mRNA CTD PMID:28329830 NCBI chr 5:173,056,352...173,139,284
Ensembl chr 5:173,056,352...173,139,284 		JBrowse link
G CRIP1 cysteine rich protein 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CRIP1 mRNA CTD PMID:28329830 NCBI chr14:105,486,886...105,488,947
Ensembl chr14:105,486,317...105,488,947 		JBrowse link
G CSDC2 cold shock domain containing C2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CSDC2 mRNA CTD PMID:28329830 NCBI chr22:41,561,010...41,576,666
Ensembl chr22:41,561,010...41,577,741 		JBrowse link
G CSGALNACT2 chondroitin sulfate N-acetylgalactosaminyltransferase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CSGALNACT2 mRNA CTD PMID:28329830 NCBI chr10:43,138,445...43,185,308
Ensembl chr10:43,138,445...43,185,302 		JBrowse link
G CSRNP1 cysteine and serine rich nuclear protein 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CSRNP1 mRNA CTD PMID:28329830 NCBI chr 3:39,141,855...39,154,641
Ensembl chr 3:39,141,855...39,154,562 		JBrowse link
G CTTNBP2NL CTTNBP2 N-terminal like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CTTNBP2NL mRNA CTD PMID:28329830 NCBI chr 1:112,391,087...112,461,164
Ensembl chr 1:112,396,214...112,463,456 		JBrowse link
G CXCL1 C-X-C motif chemokine ligand 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CXCL1 mRNA CTD PMID:28329830 NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308 		JBrowse link
G CXCL10 C-X-C motif chemokine ligand 10 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of CXCL10 mRNA CTD PMID:28329830 NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497 		JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 increases secretion
increases expression
decreases expression
multiple interactions		 EXP fluoranthene results in increased secretion of CXCL8 protein
fluoranthene results in increased expression of CXCL8 mRNA
fluoranthene results in decreased expression of CXCL8 mRNA
TNF protein promotes the reaction [fluoranthene results in increased expression of CXCL8 mRNA]; TNF protein promotes the reaction [fluoranthene results in increased secretion of CXCL8 protein]		 CTD PMID:18434080 PMID:23724284 PMID:25433334 PMID:29787794 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716 		JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 multiple interactions
increases expression
affects expression
decreases activity		 ISO
EXP		 [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A1 mRNA
[fluoranthene co-treated with pyrene] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of CYP1A1 mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of CYP1A1 protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein]; fluoranthene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]
fluoranthene results in increased expression of CYP1A1 mRNA; fluoranthene results in increased expression of CYP1A1 protein
fluoranthene affects the expression of CYP1A1 mRNA
fluoranthene results in decreased activity of CYP1A1 protein
1,2,5,6-dibenzanthracene promotes the reaction [fluoranthene results in increased expression of CYP1A1 mRNA]; Benzo(a)pyrene promotes the reaction [fluoranthene results in increased expression of CYP1A1 mRNA]; fluoranthene affects the reaction [Benzo(a)pyrene affects the expression of CYP1A1 mRNA]; fluoranthene inhibits the reaction [benzo(k)fluoranthene results in increased activity of CYP1A1 protein]; fluoranthene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; fluoranthene promotes the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 mRNA]; fluoranthene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; TNF protein inhibits the reaction [fluoranthene results in increased expression of CYP1A1 mRNA]		 CTD PMID:7750161 PMID:9586956 PMID:12107646 PMID:16269432 PMID:18711122 More... NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536 		JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 increases expression
multiple interactions		 EXP
ISO		 fluoranthene results in increased expression of CYP1A2 mRNA
[1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CYP1A2 mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of CYP1A2 mRNA
[fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA		 CTD PMID:7750161 PMID:12107646 PMID:18711122 PMID:21784029 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607 		JBrowse link
G CYP1B1 cytochrome P450 family 1 subfamily B member 1 decreases activity
multiple interactions
increases expression
affects expression		 ISO
EXP		 [fluoranthene results in decreased activity of CYP1B1 protein] which results in decreased activity of dibenzo(a,l)pyrene
[1-methylanthracene co-treated with fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1B1 mRNA; [1-methylanthracene co-treated with fluoranthene] results in increased expression of CYP1B1 mRNA
fluoranthene results in increased expression of CYP1B1 mRNA
fluoranthene affects the expression of CYP1B1 mRNA
[fluoranthene results in decreased activity of CYP1B1 protein] which results in decreased susceptibility to dibenzo(a,l)pyrene; fluoranthene affects the reaction [Benzo(a)pyrene affects the expression of CYP1B1 mRNA]; TNF protein promotes the reaction [fluoranthene results in increased expression of CYP1B1 mRNA]		 CTD PMID:17961608 PMID:25268939 PMID:27099206 PMID:27196671 PMID:28329830 More... NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902 		JBrowse link
G CYP2B6 cytochrome P450 family 2 subfamily B member 6 multiple interactions
increases expression		 EXP [fluoranthene co-treated with Benzo(a)pyrene] inhibits the reaction [pyrene results in increased expression of CYP2B6 mRNA]; [pyrene co-treated with Benzo(a)pyrene] inhibits the reaction [fluoranthene results in increased expression of CYP2B6 mRNA]; [pyrene co-treated with fluoranthene] results in increased expression of CYP2B6 mRNA; Benzo(a)pyrene inhibits the reaction [fluoranthene results in increased expression of CYP2B6 mRNA] CTD PMID:33249052 NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398 		JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 increases expression EXP fluoranthene results in increased expression of CYP2E1 mRNA CTD PMID:16269432 NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220 		JBrowse link
G CYP51A1 cytochrome P450 family 51 subfamily A member 1 decreases expression ISO fluoranthene results in decreased expression of CYP51 mRNA CTD PMID:28329830 NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803 		JBrowse link
G DDIT3 DNA damage inducible transcript 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DDIT3 mRNA CTD PMID:28329830 NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737 		JBrowse link
G DDIT4 DNA damage inducible transcript 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DDIT4 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of DDIT4 mRNA] CTD PMID:28329830 NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036 		JBrowse link
G DDX5 DEAD-box helicase 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of DDX5 mRNA CTD PMID:28329830 NCBI chr17:64,498,254...64,506,866
Ensembl chr17:64,498,254...64,508,199 		JBrowse link
G DEFB1 defensin beta 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of DEFB1 mRNA CTD PMID:28329830 NCBI chr 8:6,870,592...6,877,936
Ensembl chr 8:6,870,592...6,877,936 		JBrowse link
G DEXI Dexi homolog multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of DEXI mRNA CTD PMID:28329830 NCBI chr16:10,928,891...10,942,468
Ensembl chr16:10,928,891...10,942,468 		JBrowse link
G DHCR24 24-dehydrocholesterol reductase multiple interactions
decreases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of DHCR24 mRNA
fluoranthene results in decreased expression of DHCR24 mRNA		 CTD PMID:28329830 NCBI chr 1:54,849,627...54,887,195
Ensembl chr 1:54,849,627...54,887,195 		JBrowse link
G DHCR7 7-dehydrocholesterol reductase multiple interactions
decreases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of DHCR7 mRNA
fluoranthene results in decreased expression of DHCR7 mRNA		 CTD PMID:28329830 NCBI chr11:71,434,411...71,448,393
Ensembl chr11:71,428,193...71,452,868 		JBrowse link
G DHRS9 dehydrogenase/reductase 9 multiple interactions
increases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DHRS9 mRNA
fluoranthene results in increased expression of DHRS9 mRNA		 CTD PMID:28329830 NCBI chr 2:169,067,077...169,096,167
Ensembl chr 2:169,064,789...169,096,167 		JBrowse link
G DHX40 DEAH-box helicase 40 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DHX40 mRNA CTD PMID:28329830 NCBI chr17:59,565,610...59,608,345
Ensembl chr17:59,565,558...59,608,345 		JBrowse link
G DIP2C disco interacting protein 2 homolog C multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DIP2C mRNA CTD PMID:28329830 NCBI chr10:274,201...689,668
Ensembl chr10:274,201...689,668 		JBrowse link
G DIPK1A divergent protein kinase domain 1A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of DIPK1A mRNA CTD PMID:28329830 NCBI chr 1:92,832,729...92,961,462
Ensembl chr 1:92,832,737...92,961,522 		JBrowse link
G DLG4 discs large MAGUK scaffold protein 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DLG4 mRNA CTD PMID:28329830 NCBI chr17:7,187,187...7,220,050
Ensembl chr17:7,187,187...7,219,836 		JBrowse link
G DLX2 distal-less homeobox 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of DLX2 mRNA CTD PMID:28329830 NCBI chr 2:172,099,438...172,102,900
Ensembl chr 2:172,099,438...172,102,900 		JBrowse link
G DMAC2L distal membrane arm assembly component 2 like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of DMAC2L mRNA CTD PMID:28329830 NCBI chr14:50,311,516...50,327,957
Ensembl chr14:50,312,324...50,335,558 		JBrowse link
G DNAJB9 DnaJ heat shock protein family (Hsp40) member B9 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DNAJB9 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of DNAJB9 mRNA] CTD PMID:28329830 NCBI chr 7:108,569,874...108,574,850
Ensembl chr 7:108,569,867...108,574,850 		JBrowse link
G DNTTIP2 deoxynucleotidyltransferase terminal interacting protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DNTTIP2 mRNA CTD PMID:28329830 NCBI chr 1:93,866,284...93,879,206
Ensembl chr 1:93,866,284...93,879,918 		JBrowse link
G DOT1L DOT1 like histone lysine methyltransferase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DOT1L mRNA CTD PMID:28329830 NCBI chr19:2,163,933...2,232,578
Ensembl chr19:2,163,933...2,232,578 		JBrowse link
G DTHD1 death domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DTHD1 mRNA CTD PMID:28329830 NCBI chr 4:36,281,616...36,347,511
Ensembl chr 4:36,281,616...36,347,511 		JBrowse link
G DUSP1 dual specificity phosphatase 1 multiple interactions ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of DUSP1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of DUSP1 mRNA		 CTD PMID:18711122 PMID:28329830 NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195 		JBrowse link
G DUSP16 dual specificity phosphatase 16 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DUSP16 mRNA CTD PMID:28329830 NCBI chr12:12,473,282...12,562,863
Ensembl chr12:12,473,282...12,562,863 		JBrowse link
G DUSP4 dual specificity phosphatase 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DUSP4 mRNA CTD PMID:28329830 NCBI chr 8:29,333,064...29,350,684
Ensembl chr 8:29,333,064...29,350,684 		JBrowse link
G DUSP5 dual specificity phosphatase 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DUSP5 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of DUSP5 mRNA] CTD PMID:28329830 NCBI chr10:110,497,907...110,511,533
Ensembl chr10:110,497,907...110,511,533 		JBrowse link
G DUSP6 dual specificity phosphatase 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DUSP6 mRNA CTD PMID:28329830 NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501 		JBrowse link
G DUSP8 dual specificity phosphatase 8 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of DUSP8 mRNA CTD PMID:28329830 NCBI chr11:1,554,051...1,572,848
Ensembl chr11:1,554,051...1,572,271 		JBrowse link
G E2F8 E2F transcription factor 8 decreases expression ISO fluoranthene results in decreased expression of E2F8 mRNA CTD PMID:28329830 NCBI chr11:19,224,063...19,241,655
Ensembl chr11:19,224,063...19,241,620 		JBrowse link
G ECE1 endothelin converting enzyme 1 multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of ECE1 mRNA CTD PMID:17690111 NCBI chr 1:21,217,250...21,345,504
Ensembl chr 1:21,217,247...21,345,572 		JBrowse link
G EDN1 endothelin 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EDN1 mRNA CTD PMID:28329830 NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194 		JBrowse link
G EEA1 early endosome antigen 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EEA1 mRNA CTD PMID:28329830 NCBI chr12:92,770,637...92,929,295
Ensembl chr12:92,770,637...92,929,331 		JBrowse link
G EEIG1 estrogen-induced osteoclastogenesis regulator 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of EEIG1 mRNA CTD PMID:28329830 NCBI chr 9:127,940,582...127,980,989
Ensembl chr 9:127,940,582...127,980,989 		JBrowse link
G EFNA2 ephrin A2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of EFNA2 mRNA CTD PMID:28329830 NCBI chr19:1,284,227...1,301,431
Ensembl chr19:1,285,873...1,301,431 		JBrowse link
G EGFR epidermal growth factor receptor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EGFR mRNA CTD PMID:28329830 NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628 		JBrowse link
G EGLN1 egl-9 family hypoxia inducible factor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of EGLN1 mRNA CTD PMID:28329830 NCBI chr 1:231,363,756...231,422,287
Ensembl chr 1:231,363,751...231,422,287 		JBrowse link
G EGR1 early growth response 1 increases expression
multiple interactions		 EXP
ISO		 fluoranthene results in increased expression of EGR1 mRNA; fluoranthene results in increased expression of EGR1 protein
[1-methylanthracene co-treated with fluoranthene] results in increased expression of EGR1 mRNA		 CTD PMID:15342960 PMID:28329830 PMID:29787794 NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303 		JBrowse link
G EGR2 early growth response 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EGR2 mRNA CTD PMID:28329830 NCBI chr10:62,811,996...62,819,167
Ensembl chr10:62,811,996...62,819,167 		JBrowse link
G EHD2 EH domain containing 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of EHD2 mRNA CTD PMID:28329830 NCBI chr19:47,713,422...47,743,134
Ensembl chr19:47,713,422...47,743,134 		JBrowse link
G EHD3 EH domain containing 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of EHD3 mRNA CTD PMID:28329830 NCBI chr 2:31,234,152...31,269,451
Ensembl chr 2:31,234,152...31,269,451 		JBrowse link
G EHHADH enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase multiple interactions ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of EHHADH mRNA CTD PMID:18711122 NCBI chr 3:185,190,624...185,254,049
Ensembl chr 3:185,190,624...185,281,990 		JBrowse link
G EI24 EI24 autophagy associated transmembrane protein multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of EI24 mRNA CTD PMID:28329830 NCBI chr11:125,569,477...125,584,684
Ensembl chr11:125,569,280...125,584,684 		JBrowse link
G EID1 EP300 interacting inhibitor of differentiation 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of EID1 mRNA CTD PMID:28329830 NCBI chr15:48,878,134...48,880,173
Ensembl chr15:48,878,134...48,880,173 		JBrowse link
G EID3 EP300 interacting inhibitor of differentiation 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EID3 mRNA CTD PMID:28329830 NCBI chr12:104,303,739...104,305,205
Ensembl chr12:104,303,739...104,305,205 		JBrowse link
G EIF1B eukaryotic translation initiation factor 1B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of EIF1B mRNA CTD PMID:28329830 NCBI chr 3:40,309,707...40,312,424
Ensembl chr 3:40,309,707...40,312,424 		JBrowse link
G EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EIF2AK3 mRNA CTD PMID:28329830 NCBI chr 2:88,556,741...88,628,145
Ensembl chr 2:88,556,741...88,691,518 		JBrowse link
G ELOF1 elongation factor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ELOF1 mRNA CTD PMID:28329830 NCBI chr19:11,553,046...11,559,230
Ensembl chr19:11,551,147...11,559,230 		JBrowse link
G ELOVL1 ELOVL fatty acid elongase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ELOVL1 mRNA CTD PMID:28329830 NCBI chr 1:43,363,401...43,368,011
Ensembl chr 1:43,363,398...43,368,074 		JBrowse link
G ELOVL6 ELOVL fatty acid elongase 6 decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of ELOVL6 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of ELOVL6 mRNA		 CTD PMID:28329830 NCBI chr 4:110,045,846...110,199,202
Ensembl chr 4:110,045,846...110,199,199 		JBrowse link
G EMX2 empty spiracles homeobox 2 decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of EMX2 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of EMX2 mRNA		 CTD PMID:28329830 NCBI chr10:117,542,746...117,549,546
Ensembl chr10:117,542,445...117,549,546 		JBrowse link
G ENC1 ectodermal-neural cortex 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ENC1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of ENC1 mRNA] CTD PMID:28329830 NCBI chr 5:74,627,409...74,640,728
Ensembl chr 5:74,627,406...74,641,424 		JBrowse link
G ENTREP3 endosomal transmembrane epsin interactor 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ENTREP3 mRNA CTD PMID:28329830 NCBI chr 1:155,247,205...155,255,483
Ensembl chr 1:155,247,205...155,255,483 		JBrowse link
G EPC1 enhancer of polycomb homolog 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EPC1 mRNA CTD PMID:28329830 NCBI chr10:32,267,751...32,378,769
Ensembl chr10:32,267,751...32,378,798 		JBrowse link
G EPC2 enhancer of polycomb homolog 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EPC2 mRNA CTD PMID:28329830 NCBI chr 2:148,644,751...148,787,569
Ensembl chr 2:148,644,440...148,787,569 		JBrowse link
G EPHA2 EPH receptor A2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EPHA2 mRNA CTD PMID:28329830 NCBI chr 1:16,124,337...16,156,069
Ensembl chr 1:16,124,337...16,156,069 		JBrowse link
G EREG epiregulin multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of EREG mRNA CTD PMID:28329830 NCBI chr 4:74,365,145...74,388,749
Ensembl chr 4:74,365,145...74,388,749 		JBrowse link
G ERN1 endoplasmic reticulum to nucleus signaling 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ERN1 mRNA CTD PMID:28329830 NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819 		JBrowse link
G ERRFI1 ERBB receptor feedback inhibitor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ERRFI1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of ERRFI1 mRNA] CTD PMID:28329830 NCBI chr 1:8,011,727...8,026,309
Ensembl chr 1:8,004,404...8,026,309 		JBrowse link
G ESR1 estrogen receptor 1 multiple interactions
decreases expression		 EXP
ISO		 [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein]; fluoranthene binds to and results in increased activity of ESR1 protein; fluoranthene promotes the reaction [Estradiol results in increased activity of ESR1 protein]; Fulvestrant inhibits the reaction [fluoranthene promotes the reaction [Estradiol results in increased activity of ESR1 protein]]
fluoranthene results in decreased expression of ESR1 protein		 CTD PMID:12441364 PMID:18634860 PMID:30980910 PMID:33049310 NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619 		JBrowse link
G ESR2 estrogen receptor 2 multiple interactions EXP fluoranthene binds to and results in increased activity of ESR2 protein CTD PMID:33049310 NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112 		JBrowse link
G ETS2 ETS proto-oncogene 2, transcription factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ETS2 mRNA CTD PMID:28329830 NCBI chr21:38,805,183...38,824,955
Ensembl chr21:38,805,183...38,824,955 		JBrowse link
G ETV5 ETS variant transcription factor 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ETV5 mRNA CTD PMID:28329830 NCBI chr 3:186,046,314...186,109,089
Ensembl chr 3:186,046,314...186,110,318 		JBrowse link
G F3 coagulation factor III, tissue factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of F3 mRNA CTD PMID:28329830 NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759 		JBrowse link
G FABP1 fatty acid binding protein 1 multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of FABP1 mRNA CTD PMID:17690111 NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062 		JBrowse link
G FAM110C family with sequence similarity 110 member C multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FAM110C mRNA CTD PMID:28329830 NCBI chr 2:38,814...46,505
Ensembl chr 2:38,814...46,870 		JBrowse link
G FAM118A family with sequence similarity 118 member A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FAM118A mRNA CTD PMID:28329830 NCBI chr22:45,308,960...45,341,955
Ensembl chr22:45,308,968...45,341,955 		JBrowse link
G FAM136A family with sequence similarity 136 member A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FAM136A mRNA CTD PMID:28329830 NCBI chr 2:70,295,976...70,302,067
Ensembl chr 2:70,295,976...70,302,067 		JBrowse link
G FAM13B family with sequence similarity 13 member B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FAM13B mRNA CTD PMID:28329830 NCBI chr 5:137,937,960...138,052,178
Ensembl chr 5:137,937,960...138,051,961 		JBrowse link
G FAM149A family with sequence similarity 149 member A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FAM149A mRNA CTD PMID:28329830 NCBI chr 4:186,104,704...186,175,337
Ensembl chr 4:186,104,419...186,175,337 		JBrowse link
G FAM162A family with sequence similarity 162 member A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FAM162A mRNA CTD PMID:28329830 NCBI chr 3:122,384,182...122,412,334
Ensembl chr 3:122,384,161...122,412,334 		JBrowse link
G FAM83H family with sequence similarity 83 member H multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FAM83H mRNA CTD PMID:28329830 NCBI chr 8:143,723,933...143,733,779
Ensembl chr 8:143,723,933...143,738,234 		JBrowse link
G FBXO32 F-box protein 32 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FBXO32 mRNA CTD PMID:28329830 NCBI chr 8:123,497,889...123,541,206
Ensembl chr 8:123,497,889...123,541,206 		JBrowse link
G FBXO33 F-box protein 33 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FBXO33 mRNA CTD PMID:28329830 NCBI chr14:39,397,684...39,432,433
Ensembl chr14:39,397,684...39,432,466 		JBrowse link
G FDFT1 farnesyl-diphosphate farnesyltransferase 1 decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of FDFT1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of FDFT1 mRNA		 CTD PMID:28329830 NCBI chr 8:11,795,582...11,839,309
Ensembl chr 8:11,795,573...11,839,395 		JBrowse link
G FDPS farnesyl diphosphate synthase multiple interactions
decreases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FDPS mRNA
fluoranthene results in decreased expression of FDPS mRNA		 CTD PMID:28329830 NCBI chr 1:155,308,866...155,320,665
Ensembl chr 1:155,308,748...155,320,666 		JBrowse link
G FGD6 FYVE, RhoGEF and PH domain containing 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FGD6 mRNA CTD PMID:28329830 NCBI chr12:95,076,749...95,217,467
Ensembl chr12:95,076,749...95,217,482 		JBrowse link
G FGF18 fibroblast growth factor 18 decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of FGF18 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of FGF18 mRNA		 CTD PMID:28329830 NCBI chr 5:171,419,647...171,457,626
Ensembl chr 5:171,419,647...171,457,626 		JBrowse link
G FGF2 fibroblast growth factor 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FGF2 mRNA CTD PMID:28329830 NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236 		JBrowse link
G FGF21 fibroblast growth factor 21 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FGF21 mRNA CTD PMID:28329830 NCBI chr19:48,755,524...48,758,330
Ensembl chr19:48,755,524...48,758,333 		JBrowse link
G FGF5 fibroblast growth factor 5 multiple interactions
increases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FGF5 mRNA
fluoranthene results in increased expression of FGF5 mRNA		 CTD PMID:28329830 NCBI chr 4:80,266,588...80,291,017
Ensembl chr 4:80,266,639...80,336,680 		JBrowse link
G FGF7 fibroblast growth factor 7 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FGF7 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of FGF7 mRNA] CTD PMID:28329830 NCBI chr15:49,423,242...49,488,775
Ensembl chr15:49,423,237...49,488,775 		JBrowse link
G FN3KRP fructosamine 3 kinase related protein multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FN3KRP mRNA CTD PMID:28329830 NCBI chr17:82,716,706...82,728,013
Ensembl chr17:82,716,706...82,730,328 		JBrowse link
G FNIP2 folliculin interacting protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FNIP2 mRNA CTD PMID:28329830 NCBI chr 4:158,769,026...158,908,050
Ensembl chr 4:158,769,026...158,908,050 		JBrowse link
G FOS Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FOS mRNA CTD PMID:28329830 NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230 		JBrowse link
G FOSL1 FOS like 1, AP-1 transcription factor subunit multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FOSL1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of FOSL1 mRNA] CTD PMID:28329830 NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573 		JBrowse link
G FOSL2 FOS like 2, AP-1 transcription factor subunit multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FOSL2 mRNA CTD PMID:28329830 NCBI chr 2:28,392,858...28,417,317
Ensembl chr 2:28,392,448...28,417,317 		JBrowse link
G FOXF2 forkhead box F2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FOXF2 mRNA CTD PMID:28329830 NCBI chr 6:1,389,576...1,395,603
Ensembl chr 6:1,389,576...1,395,603 		JBrowse link
G FOXJ3 forkhead box J3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FOXJ3 mRNA CTD PMID:28329830 NCBI chr 1:42,176,548...42,335,880
Ensembl chr 1:42,176,539...42,335,877 		JBrowse link
G FOXO6 forkhead box O6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of FOXO6 mRNA CTD PMID:28329830 NCBI chr 1:41,361,434...41,383,590
Ensembl chr 1:41,361,922...41,383,590 		JBrowse link
G FST follistatin multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FST mRNA CTD PMID:28329830 NCBI chr 5:53,480,629...53,487,134
Ensembl chr 5:53,480,626...53,487,134 		JBrowse link
G FUT11 fucosyltransferase 11 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of FUT11 mRNA CTD PMID:28329830 NCBI chr10:73,772,276...73,780,254
Ensembl chr10:73,772,276...73,780,251 		JBrowse link
G FZD2 frizzled class receptor 2 decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of FZD2 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of FZD2 mRNA		 CTD PMID:28329830 NCBI chr17:44,557,484...44,561,262
Ensembl chr17:44,557,484...44,561,262 		JBrowse link
G G6PD glucose-6-phosphate dehydrogenase multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of G6PD mRNA CTD PMID:17690111 NCBI chr  X:154,531,390...154,547,569
Ensembl chr  X:154,517,825...154,547,572 		JBrowse link
G GAB2 GRB2 associated binding protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GAB2 mRNA CTD PMID:28329830 NCBI chr11:78,215,293...78,417,820
Ensembl chr11:78,215,293...78,418,348 		JBrowse link
G GADD45A growth arrest and DNA damage inducible alpha multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GADD45A mRNA CTD PMID:28329830 NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334 		JBrowse link
G GADD45B growth arrest and DNA damage inducible beta multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GADD45B mRNA CTD PMID:28329830 NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,259 		JBrowse link
G GADD45G growth arrest and DNA damage inducible gamma decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of GADD45G mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of GADD45G mRNA; [1-methylanthracene co-treated with fluoranthene] results in increased expression of GADD45G mRNA		 CTD PMID:28329830 NCBI chr 9:89,605,012...89,606,555
Ensembl chr 9:89,605,012...89,606,555 		JBrowse link
G GALNT12 polypeptide N-acetylgalactosaminyltransferase 12 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of GALNT12 mRNA CTD PMID:28329830 NCBI chr 9:98,807,670...98,850,081
Ensembl chr 9:98,807,670...98,850,081 		JBrowse link
G GATA2 GATA binding protein 2 multiple interactions
decreases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of GATA2 mRNA
fluoranthene results in decreased expression of GATA2 mRNA		 CTD PMID:28329830 NCBI chr 3:128,479,422...128,493,201
Ensembl chr 3:128,479,427...128,493,201 		JBrowse link
G GATA4 GATA binding protein 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GATA4 mRNA CTD PMID:28329830 NCBI chr 8:11,676,935...11,760,002
Ensembl chr 8:11,676,959...11,760,002 		JBrowse link
G GCH1 GTP cyclohydrolase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GCH1 mRNA CTD PMID:28329830 NCBI chr14:54,842,017...54,902,826
Ensembl chr14:54,842,008...54,902,826 		JBrowse link
G GCK glucokinase multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of GCK mRNA CTD PMID:17690111 NCBI chr 7:44,143,213...44,189,439
Ensembl chr 7:44,143,213...44,198,170 		JBrowse link
G GDNF glial cell derived neurotrophic factor multiple interactions
increases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GDNF mRNA
fluoranthene results in increased expression of GDNF mRNA		 CTD PMID:28329830 NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041 		JBrowse link
G GDPGP1 GDP-D-glucose phosphorylase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of GDPGP1 mRNA CTD PMID:28329830 NCBI chr15:90,234,209...90,245,811
Ensembl chr15:90,233,808...90,245,811 		JBrowse link
G GFOD1 Gfo/Idh/MocA-like oxidoreductase domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GFOD1 mRNA CTD PMID:28329830 NCBI chr 6:13,357,830...13,487,600
Ensembl chr 6:13,357,830...13,487,662 		JBrowse link
G GJA1 gap junction protein alpha 1 multiple interactions
decreases localization
decreases expression		 ISO [1-methylanthracene co-treated with fluoranthene co-treated with Benzo(a)pyrene] results in decreased expression of GJA1 mRNA; [1-methylanthracene co-treated with fluoranthene co-treated with Benzo(a)pyrene] results in decreased expression of GJA1 protein; [1-methylanthracene co-treated with fluoranthene] results in increased degradation of and results in decreased expression of GJA1 protein; fluoranthene results in increased degradation of and results in decreased expression of GJA1 protein
fluoranthene results in decreased localization of GJA1 protein
fluoranthene results in decreased expression of GJA1 protein		 CTD PMID:28329830 PMID:29170806 PMID:30668803 NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727 		JBrowse link
G GJB1 gap junction protein beta 1 decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of GJB1 protein
[1-methylanthracene co-treated with fluoranthene] affects the expression of and affects the activity of GJB1 protein; fluoranthene affects the expression of and affects the activity of GJB1 protein; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] affects the expression of and affects the activity of GJB1 protein]; SB 203580 inhibits the reaction [fluoranthene affects the expression of and affects the activity of GJB1 protein]		 CTD PMID:25268939 PMID:28329830 NCBI chr  X:71,215,239...71,225,516
Ensembl chr  X:71,212,811...71,225,516 		JBrowse link
G GLIS2 GLIS family zinc finger 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of GLIS2 mRNA CTD PMID:28329830 NCBI chr16:4,314,761...4,339,595
Ensembl chr16:4,314,761...4,339,597 		JBrowse link
G GLRX glutaredoxin decreases expression ISO fluoranthene results in decreased expression of GLRX mRNA CTD PMID:28329830 NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,726 		JBrowse link
G GLRX5 glutaredoxin 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of GLRX5 mRNA CTD PMID:28329830 NCBI chr14:95,535,050...95,544,714
Ensembl chr14:95,533,503...95,544,724 		JBrowse link
G GNB4 G protein subunit beta 4 increases expression
multiple interactions		 ISO fluoranthene results in increased expression of GNB4 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of GNB4 mRNA		 CTD PMID:28329830 NCBI chr 3:179,396,088...179,527,798
Ensembl chr 3:179,396,088...179,451,476 		JBrowse link
G GNL3 G protein nucleolar 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GNL3 mRNA CTD PMID:28329830 NCBI chr 3:52,685,920...52,694,497
Ensembl chr 3:52,681,156...52,694,497 		JBrowse link
G GOLGA5 golgin A5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GOLGA5 mRNA CTD PMID:28329830 NCBI chr14:92,794,305...92,839,947
Ensembl chr14:92,794,305...92,839,947 		JBrowse link
G GORAB golgin, RAB6 interacting multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GORAB mRNA CTD PMID:28329830 NCBI chr 1:170,532,166...170,553,834
Ensembl chr 1:170,531,819...170,553,834 		JBrowse link
G GPATCH11 G-patch domain containing 11 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of GPATCH11 mRNA CTD PMID:28329830 NCBI chr 2:37,084,518...37,099,244
Ensembl chr 2:37,084,518...37,099,244 		JBrowse link
G GPD1L glycerol-3-phosphate dehydrogenase 1 like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of GPD1L mRNA CTD PMID:28329830 NCBI chr 3:32,106,620...32,168,709
Ensembl chr 3:32,105,689...32,168,709 		JBrowse link
G GRAMD1B GRAM domain containing 1B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GRAMD1B mRNA CTD PMID:28329830 NCBI chr11:123,358,422...123,627,767
Ensembl chr11:123,358,428...123,627,774 		JBrowse link
G GRAMD4 GRAM domain containing 4 increases expression
multiple interactions		 ISO fluoranthene results in increased expression of GRAMD4 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of GRAMD4 mRNA		 CTD PMID:28329830 NCBI chr22:46,575,744...46,682,756
Ensembl chr22:46,576,012...46,679,790 		JBrowse link
G GSDME gasdermin E increases expression ISO fluoranthene results in increased expression of GSDME mRNA CTD PMID:28329830 NCBI chr 7:24,698,355...24,795,539
Ensembl chr 7:24,698,355...24,757,940 		JBrowse link
G GSTT3P glutathione S-transferase theta 3, pseudogene multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of GSTT3 mRNA CTD PMID:28329830
G GTPBP2 GTP binding protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GTPBP2 mRNA CTD PMID:28329830 NCBI chr 6:43,620,494...43,631,333
Ensembl chr 6:43,605,316...43,629,264 		JBrowse link
G GTPBP4 GTP binding protein 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of GTPBP4 mRNA CTD PMID:28329830 NCBI chr10:988,434...1,019,932
Ensembl chr10:988,434...1,019,932 		JBrowse link
G GYS1 glycogen synthase 1 decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of GYS1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of GYS1 mRNA		 CTD PMID:28329830 NCBI chr19:48,968,130...48,993,309
Ensembl chr19:48,968,130...48,993,310 		JBrowse link
G H1-2 H1.2 linker histone, cluster member decreases expression ISO fluoranthene results in decreased expression of H1F2 mRNA CTD PMID:28329830 NCBI chr 6:26,055,740...26,056,470
Ensembl chr 6:26,055,740...26,056,470 		JBrowse link
G H2AC20 H2A clustered histone 20 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of H2AC20 mRNA CTD PMID:28329830 NCBI chr 1:149,886,918...149,887,411
Ensembl chr 1:149,886,918...149,887,411 		JBrowse link
G H2AX H2A.X variant histone multiple interactions ISO
EXP		 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of H2AX mRNA
[fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of H2AX protein; [pyrene co-treated with fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of H2AX protein		 CTD PMID:28329830 PMID:33249052 NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465 		JBrowse link
G H2BC8 H2B clustered histone 8 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of H2BC8 mRNA CTD PMID:28329830 NCBI chr 6:26,216,200...26,216,688
Ensembl chr 6:26,216,200...26,216,688 		JBrowse link
G HACD4 3-hydroxyacyl-CoA dehydratase 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HACD4 mRNA CTD PMID:28329830 NCBI chr 9:20,999,509...21,031,640
Ensembl chr 9:20,999,509...21,031,640 		JBrowse link
G HAS2 hyaluronan synthase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HAS2 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of HAS2 mRNA] CTD PMID:28329830 NCBI chr 8:121,612,116...121,641,440
Ensembl chr 8:121,612,116...121,641,440 		JBrowse link
G HBEGF heparin binding EGF like growth factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HBEGF mRNA CTD PMID:28329830 NCBI chr 5:140,332,843...140,346,603
Ensembl chr 5:140,332,843...140,346,603 		JBrowse link
G HCFC1R1 host cell factor C1 regulator 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HCFC1R1 mRNA CTD PMID:28329830 NCBI chr16:3,022,620...3,024,286
Ensembl chr16:3,022,625...3,024,286 		JBrowse link
G HCN2 hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HCN2 mRNA CTD PMID:28329830 NCBI chr19:589,881...617,159
Ensembl chr19:589,881...617,159 		JBrowse link
G HDAC4 histone deacetylase 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HDAC4 mRNA CTD PMID:28329830 NCBI chr 2:239,048,168...239,401,649
Ensembl chr 2:239,048,168...239,401,654 		JBrowse link
G HDDC2 HD domain containing 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HDDC2 mRNA CTD PMID:28329830 NCBI chr 6:125,275,350...125,301,967
Ensembl chr 6:125,219,962...125,302,078 		JBrowse link
G HERPUD1 homocysteine inducible ER protein with ubiquitin like domain 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HERPUD1 mRNA CTD PMID:28329830 NCBI chr16:56,932,142...56,944,864
Ensembl chr16:56,932,142...56,944,864 		JBrowse link
G HES1 hes family bHLH transcription factor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HES1 mRNA CTD PMID:28329830 NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732 		JBrowse link
G HGSNAT heparan-alpha-glucosaminide N-acetyltransferase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HGSNAT mRNA CTD PMID:28329830 NCBI chr 8:43,140,464...43,202,855
Ensembl chr 8:43,140,464...43,202,855 		JBrowse link
G HIF1A hypoxia inducible factor 1 subunit alpha multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of HIF1A mRNA CTD PMID:17690111 NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259 		JBrowse link
G HIGD1A HIG1 hypoxia inducible domain family member 1A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HIGD1A mRNA CTD PMID:28329830 NCBI chr 3:42,782,908...42,804,490
Ensembl chr 3:42,782,908...42,804,490 		JBrowse link
G HINFP histone H4 transcription factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HINFP mRNA CTD PMID:28329830 NCBI chr11:119,121,580...119,136,059
Ensembl chr11:119,121,580...119,136,059 		JBrowse link
G HIVEP2 HIVEP zinc finger 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HIVEP2 mRNA CTD PMID:28329830 NCBI chr 6:142,751,469...142,946,365
Ensembl chr 6:142,751,469...142,956,698 		JBrowse link
G HMGA2 high mobility group AT-hook 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HMGA2 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of HMGA2 mRNA] CTD PMID:28329830 NCBI chr12:65,824,460...65,966,291
Ensembl chr12:65,824,460...65,966,291 		JBrowse link
G HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase multiple interactions
decreases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HMGCR mRNA
fluoranthene results in decreased expression of HMGCR mRNA		 CTD PMID:28329830 NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001 		JBrowse link
G HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of HMGCS1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of HMGCS1 mRNA		 CTD PMID:28329830 NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512 		JBrowse link
G HMOX1 heme oxygenase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HMOX1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of HMOX1 mRNA] CTD PMID:28329830 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214 		JBrowse link
G HS6ST1 heparan sulfate 6-O-sulfotransferase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HS6ST1 mRNA CTD PMID:28329830 NCBI chr 2:128,265,480...128,318,868
Ensembl chr 2:128,236,716...128,318,868 		JBrowse link
G HSBP1 heat shock factor binding protein 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HSBP1 mRNA CTD PMID:28329830 NCBI chr16:83,807,978...83,819,737
Ensembl chr16:83,719,311...83,819,737 		JBrowse link
G HSD11B1 hydroxysteroid 11-beta dehydrogenase 1 multiple interactions ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of HSD11B1 mRNA CTD PMID:18711122 NCBI chr 1:209,686,179...209,734,929
Ensembl chr 1:209,686,178...209,734,949 		JBrowse link
G HSD17B7 hydroxysteroid 17-beta dehydrogenase 7 multiple interactions
decreases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HSD17B7 mRNA
fluoranthene results in decreased expression of HSD17B7 mRNA		 CTD PMID:28329830 NCBI chr 1:162,790,702...162,812,823
Ensembl chr 1:162,790,702...162,812,823 		JBrowse link
G HSPA1B heat shock protein family A (Hsp70) member 1B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HSPA1B mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of HSPA1B mRNA] CTD PMID:28329830 NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254 		JBrowse link
G HSPA5 heat shock protein family A (Hsp70) member 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of HSPA5 mRNA CTD PMID:28329830 NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382 		JBrowse link
G ICAM1 intercellular adhesion molecule 1 increases expression EXP fluoranthene results in increased expression of ICAM1 protein CTD PMID:22313677 NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615 		JBrowse link
G ID1 inhibitor of DNA binding 1 multiple interactions
decreases expression		 ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ID1 mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of ID1 mRNA
fluoranthene results in decreased expression of ID1 mRNA		 CTD PMID:18711122 PMID:28329830 NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515 		JBrowse link
G IDH1 isocitrate dehydrogenase (NADP(+)) 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of IDH1 mRNA CTD PMID:28329830 NCBI chr 2:208,236,227...208,255,071
Ensembl chr 2:208,236,229...208,266,074 		JBrowse link
G IDI1 isopentenyl-diphosphate delta isomerase 1 decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of IDI1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of IDI1 mRNA		 CTD PMID:28329830 NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119 		JBrowse link
G IER2 immediate early response 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IER2 mRNA CTD PMID:28329830 NCBI chr19:13,150,411...13,154,911
Ensembl chr19:13,150,411...13,154,911 		JBrowse link
G IER3 immediate early response 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IER3 mRNA CTD PMID:28329830 NCBI chr 6:30,743,199...30,744,547
Ensembl chr 6:30,743,199...30,744,548 		JBrowse link
G IER5 immediate early response 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IER5 mRNA CTD PMID:28329830 NCBI chr 1:181,088,700...181,092,900
Ensembl chr 1:181,088,700...181,092,900 		JBrowse link
G IFI16 interferon gamma inducible protein 16 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IFI204 mRNA CTD PMID:28329830 NCBI chr 1:158,999,976...159,055,151
Ensembl chr 1:158,999,968...159,055,155 		JBrowse link
G IFI30 IFI30 lysosomal thiol reductase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of IFI30 mRNA CTD PMID:28329830 NCBI chr19:18,173,813...18,178,117
Ensembl chr19:18,173,162...18,178,117 		JBrowse link
G IFNG interferon gamma increases expression EXP fluoranthene results in increased expression of IFNG mRNA CTD PMID:18434080 NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740 		JBrowse link
G IFRD1 interferon related developmental regulator 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IFRD1 mRNA CTD PMID:28329830 NCBI chr 7:112,423,174...112,477,203
Ensembl chr 7:112,422,887...112,481,017 		JBrowse link
G IFT70B intraflagellar transport 70B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of IFT70B mRNA CTD PMID:28329830 NCBI chr 2:177,548,998...177,552,796
Ensembl chr 2:177,548,998...177,552,796 		JBrowse link
G IGF1 insulin like growth factor 1 multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of IGF1 mRNA CTD PMID:17690111 NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744 		JBrowse link
G IGSF3 immunoglobulin superfamily member 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IGSF3 mRNA CTD PMID:28329830 NCBI chr 1:116,574,398...116,667,755
Ensembl chr 1:116,574,399...116,667,755 		JBrowse link
G IL12RB1 interleukin 12 receptor subunit beta 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IL12RB1 mRNA CTD PMID:28329830 NCBI chr19:18,058,995...18,098,816
Ensembl chr19:18,058,995...18,098,944 		JBrowse link
G IL13RA1 interleukin 13 receptor subunit alpha 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IL13RA1 mRNA CTD PMID:28329830 NCBI chr  X:118,727,606...118,805,228
Ensembl chr  X:118,727,133...118,794,535 		JBrowse link
G IL13RA2 interleukin 13 receptor subunit alpha 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IL13RA2 mRNA CTD PMID:28329830 NCBI chr  X:115,003,982...115,017,616
Ensembl chr  X:115,003,975...115,019,977 		JBrowse link
G IL17RA interleukin 17 receptor A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IL17RA mRNA CTD PMID:28329830 NCBI chr22:17,085,000...17,115,693
Ensembl chr22:17,084,954...17,115,693 		JBrowse link
G IL22RA1 interleukin 22 receptor subunit alpha 1 multiple interactions
decreases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of IL22RA1 mRNA
fluoranthene results in decreased expression of IL22RA1 mRNA		 CTD PMID:28329830 NCBI chr 1:24,119,771...24,143,140
Ensembl chr 1:24,119,771...24,143,140 		JBrowse link
G IL4 interleukin 4 increases expression
multiple interactions		 EXP fluoranthene results in increased expression of IL4 mRNA
TNF protein inhibits the reaction [fluoranthene results in increased expression of IL4 mRNA]		 CTD PMID:18434080 NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678 		JBrowse link
G IL6 interleukin 6 increases expression
increases secretion
multiple interactions		 EXP
ISO		 fluoranthene results in increased expression of IL6 mRNA
fluoranthene results in increased secretion of IL6 protein
[1-methylanthracene co-treated with fluoranthene] results in increased expression of IL6 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of IL6 mRNA]
TNF protein promotes the reaction [fluoranthene results in increased expression of IL6 mRNA]		 CTD PMID:18434080 PMID:28329830 PMID:29787794 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002 		JBrowse link
G IL6R interleukin 6 receptor decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of IL6RA mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of IL6RA mRNA		 CTD PMID:28329830 NCBI chr 1:154,405,343...154,469,450
Ensembl chr 1:154,405,193...154,469,450 		JBrowse link
G ILDR2 immunoglobulin like domain containing receptor 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ILDR2 mRNA CTD PMID:28329830 NCBI chr 1:166,908,187...166,975,540
Ensembl chr 1:166,895,711...166,975,540 		JBrowse link
G INKA2 inka box actin regulator 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of INKA2 mRNA CTD PMID:28329830 NCBI chr 1:111,722,064...111,755,797
Ensembl chr 1:111,680,630...111,755,824 		JBrowse link
G INSIG1 insulin induced gene 1 decreases expression ISO fluoranthene results in decreased expression of INSIG1 mRNA CTD PMID:28329830 NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235 		JBrowse link
G IPO7 importin 7 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IPO7 mRNA CTD PMID:28329830 NCBI chr11:9,384,652...9,448,127
Ensembl chr11:9,384,652...9,448,127 		JBrowse link
G IQCF5 IQ motif containing F5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of IQCF5 mRNA CTD PMID:28329830 NCBI chr 3:51,873,721...51,875,601
Ensembl chr 3:51,873,721...51,875,601 		JBrowse link
G IRAK2 interleukin 1 receptor associated kinase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IRAK2 mRNA CTD PMID:28329830 NCBI chr 3:10,164,919...10,243,745
Ensembl chr 3:10,164,919...10,243,745 		JBrowse link
G IRF1 interferon regulatory factor 1 increases expression
multiple interactions		 ISO fluoranthene results in increased expression of IRF1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of IRF1 mRNA		 CTD PMID:28329830 NCBI chr 5:132,481,609...132,490,773
Ensembl chr 5:132,440,440...132,508,719 		JBrowse link
G IRF2 interferon regulatory factor 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IRF2 mRNA CTD PMID:28329830 NCBI chr 4:184,387,729...184,474,550
Ensembl chr 4:184,385,702...184,474,558 		JBrowse link
G IRF2BP2 interferon regulatory factor 2 binding protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IRF2BP2 mRNA CTD PMID:28329830 NCBI chr 1:234,604,269...234,610,178
Ensembl chr 1:234,604,269...234,610,178 		JBrowse link
G IRF2BPL interferon regulatory factor 2 binding protein like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IRF2BPL mRNA CTD PMID:28329830 NCBI chr14:77,024,543...77,028,708
Ensembl chr14:77,024,543...77,028,708 		JBrowse link
G IRGM immunity related GTPase M multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of IRGM1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of IRGM1 mRNA] CTD PMID:28329830 NCBI chr 5:150,846,521...150,902,402
Ensembl chr 5:150,846,521...150,900,736 		JBrowse link
G ITGB8 integrin subunit beta 8 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ITGB8 mRNA CTD PMID:28329830 NCBI chr 7:20,329,766...20,415,754
Ensembl chr 7:20,330,702...20,415,754 		JBrowse link
G ITPRIP inositol 1,4,5-trisphosphate receptor interacting protein multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ITPRIP mRNA CTD PMID:28329830 NCBI chr10:104,309,700...104,338,465
Ensembl chr10:104,309,698...104,338,465 		JBrowse link
G JDP2 Jun dimerization protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of JDP2 mRNA CTD PMID:28329830 NCBI chr14:75,426,943...75,474,107
Ensembl chr14:75,427,716...75,474,111 		JBrowse link
G JMJD1C jumonji domain containing 1C multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of JMJD1C mRNA CTD PMID:28329830 NCBI chr10:63,167,225...63,521,890
Ensembl chr10:63,167,221...63,521,850 		JBrowse link
G JRKL JRK like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of JRKL mRNA CTD PMID:28329830 NCBI chr11:96,390,013...96,393,561
Ensembl chr11:96,389,989...96,507,574 		JBrowse link
G JUN Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of JUN mRNA CTD PMID:28329830 NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048 		JBrowse link
G JUNB JunB proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of JUNB mRNA CTD PMID:28329830 NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315 		JBrowse link
G KATNBL1 katanin regulatory subunit B1 like 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KATNBL1 mRNA CTD PMID:28329830 NCBI chr15:34,140,674...34,210,096
Ensembl chr15:34,140,674...34,210,096 		JBrowse link
G KBTBD2 kelch repeat and BTB domain containing 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KBTBD2 mRNA CTD PMID:28329830 NCBI chr 7:32,868,172...32,892,166
Ensembl chr 7:32,868,172...32,894,131 		JBrowse link
G KCTD21 potassium channel tetramerization domain containing 21 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of KCTD21 mRNA CTD PMID:28329830 NCBI chr11:78,171,249...78,188,626
Ensembl chr11:78,171,249...78,188,626 		JBrowse link
G KDM5A lysine demethylase 5A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KDM5A mRNA CTD PMID:28329830 NCBI chr12:280,057...389,320
Ensembl chr12:280,057...389,320 		JBrowse link
G KDM7A lysine demethylase 7A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KDM7A mRNA CTD PMID:28329830 NCBI chr 7:140,084,746...140,176,983
Ensembl chr 7:140,084,746...140,176,983 		JBrowse link
G KIF21B kinesin family member 21B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KIF21B mRNA CTD PMID:28329830 NCBI chr 1:200,969,390...201,023,714
Ensembl chr 1:200,969,390...201,023,714 		JBrowse link
G KLF10 KLF transcription factor 10 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF10 mRNA CTD PMID:28329830 NCBI chr 8:102,648,784...102,655,725
Ensembl chr 8:102,648,784...102,655,725 		JBrowse link
G KLF4 KLF transcription factor 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF4 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF4 mRNA] CTD PMID:28329830 NCBI chr 9:107,484,852...107,489,769
Ensembl chr 9:107,484,852...107,490,482 		JBrowse link
G KLF5 KLF transcription factor 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF5 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF5 mRNA] CTD PMID:28329830 NCBI chr13:73,054,976...73,077,538
Ensembl chr13:73,054,976...73,077,541 		JBrowse link
G KLF6 KLF transcription factor 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF6 mRNA CTD PMID:28329830 NCBI chr10:3,775,996...3,785,209
Ensembl chr10:3,775,996...3,785,281 		JBrowse link
G KLF9 KLF transcription factor 9 multiple interactions
increases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF9 mRNA
fluoranthene results in increased expression of KLF9 mRNA		 CTD PMID:28329830 NCBI chr 9:70,384,604...70,414,657
Ensembl chr 9:70,384,604...70,414,657 		JBrowse link
G KLHL21 kelch like family member 21 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of KLHL21 mRNA CTD PMID:28329830 NCBI chr 1:6,590,724...6,602,869
Ensembl chr 1:6,590,724...6,614,607 		JBrowse link
G KLHL42 kelch like family member 42 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of KLHL42 mRNA CTD PMID:28329830 NCBI chr12:27,780,233...27,803,040
Ensembl chr12:27,780,048...27,803,040 		JBrowse link
G KPNA2 karyopherin subunit alpha 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of KPNA2 mRNA CTD PMID:28329830 NCBI chr17:68,035,735...68,046,854
Ensembl chr17:68,035,636...68,047,364 		JBrowse link
G KYAT3 kynurenine aminotransferase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of KYAT3 mRNA CTD PMID:28329830 NCBI chr 1:88,921,044...88,992,960
Ensembl chr 1:88,935,773...88,992,953 		JBrowse link
G L2HGDH L-2-hydroxyglutarate dehydrogenase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of L2HGDH mRNA CTD PMID:28329830 NCBI chr14:50,242,434...50,312,229
Ensembl chr14:50,237,563...50,312,229 		JBrowse link
G LBP lipopolysaccharide binding protein multiple interactions ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of LBP mRNA CTD PMID:18711122 NCBI chr20:38,346,482...38,377,013
Ensembl chr20:38,346,482...38,377,013 		JBrowse link
G LDHA lactate dehydrogenase A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LDHA mRNA CTD PMID:28329830 NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425 		JBrowse link
G LDLR low density lipoprotein receptor decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of LDLR mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of LDLR mRNA		 CTD PMID:28329830 NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820 		JBrowse link
G LENG8 leukocyte receptor cluster member 8 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LENG8 mRNA CTD PMID:28329830 NCBI chr19:54,449,199...54,462,016
Ensembl chr19:54,449,190...54,462,016 		JBrowse link
G LEPROT leptin receptor overlapping transcript multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LEPROT mRNA CTD PMID:28329830 NCBI chr 1:65,420,668...65,436,007
Ensembl chr 1:65,420,587...65,436,007 		JBrowse link
G LFNG LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LFNG mRNA CTD PMID:28329830 NCBI chr 7:2,512,529...2,529,177
Ensembl chr 7:2,512,529...2,529,177 		JBrowse link
G LGALS9 galectin 9 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LGALS9 mRNA CTD PMID:28329830 NCBI chr17:27,631,188...27,649,560
Ensembl chr17:27,629,798...27,649,560 		JBrowse link
G LIF LIF interleukin 6 family cytokine multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LIF mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of LIF mRNA] CTD PMID:28329830 NCBI chr22:30,240,453...30,246,759
Ensembl chr22:30,240,453...30,246,759 		JBrowse link
G LMCD1 LIM and cysteine rich domains 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LMCD1 mRNA CTD PMID:28329830 NCBI chr 3:8,501,823...8,574,668
Ensembl chr 3:8,501,807...8,574,668 		JBrowse link
G LMLN leishmanolysin like peptidase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LMLN mRNA CTD PMID:28329830 NCBI chr 3:197,960,217...198,043,720
Ensembl chr 3:197,960,200...198,043,720 		JBrowse link
G LMNB1 lamin B1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LMNB1 mRNA CTD PMID:28329830 NCBI chr 5:126,776,623...126,837,020
Ensembl chr 5:126,776,623...126,837,020 		JBrowse link
G LMO4 LIM domain only 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LMO4 mRNA CTD PMID:28329830 NCBI chr 1:87,328,880...87,348,923
Ensembl chr 1:87,328,880...87,348,923 		JBrowse link
G LPCAT3 lysophosphatidylcholine acyltransferase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LPCAT3 mRNA CTD PMID:28329830 NCBI chr12:6,976,185...7,018,476
Ensembl chr12:6,976,185...7,018,477 		JBrowse link
G LPIN1 lipin 1 decreases expression ISO fluoranthene results in decreased expression of LPIN1 mRNA CTD PMID:28329830 NCBI chr 2:11,677,544...11,827,409
Ensembl chr 2:11,677,595...11,827,409 		JBrowse link
G LRIG1 leucine rich repeats and immunoglobulin like domains 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LRIG1 mRNA CTD PMID:28329830 NCBI chr 3:66,378,797...66,501,121
Ensembl chr 3:66,378,797...66,501,263 		JBrowse link
G LRRC2 leucine rich repeat containing 2 multiple interactions
increases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LRRC2 mRNA
fluoranthene results in increased expression of LRRC2 mRNA		 CTD PMID:28329830 NCBI chr 3:46,515,385...46,566,302
Ensembl chr 3:46,515,385...46,606,948 		JBrowse link
G LRRC8C leucine rich repeat containing 8 VRAC subunit C multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LRRC8C mRNA CTD PMID:28329830 NCBI chr 1:89,615,824...89,719,533
Ensembl chr 1:89,633,072...89,769,903 		JBrowse link
G LRRC8D leucine rich repeat containing 8 VRAC subunit D multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LRRC8D mRNA CTD PMID:28329830 NCBI chr 1:89,821,032...89,936,611
Ensembl chr 1:89,821,014...89,936,611 		JBrowse link
G LSS lanosterol synthase decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of LSS mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of LSS mRNA		 CTD PMID:28329830 NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824 		JBrowse link
G LURAP1L leucine rich adaptor protein 1 like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LURAP1L mRNA CTD PMID:28329830 NCBI chr 9:12,775,020...12,823,060
Ensembl chr 9:12,775,020...12,823,060 		JBrowse link
G LY96 lymphocyte antigen 96 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LY96 mRNA CTD PMID:28329830 NCBI chr 8:73,991,392...74,099,857
Ensembl chr 8:73,991,392...74,029,079 		JBrowse link
G LYSMD3 LysM domain containing 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LYSMD3 mRNA CTD PMID:28329830 NCBI chr 5:90,515,626...90,529,584
Ensembl chr 5:90,515,611...90,529,584 		JBrowse link
G LYST lysosomal trafficking regulator multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of LYST mRNA CTD PMID:28329830 NCBI chr 1:235,661,031...235,883,713
Ensembl chr 1:235,661,041...235,883,724 		JBrowse link
G MAF MAF bZIP transcription factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MAF mRNA CTD PMID:28329830 NCBI chr16:79,202,622...79,600,737
Ensembl chr16:79,585,843...79,600,737 		JBrowse link
G MAFF MAF bZIP transcription factor F multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MAFF mRNA CTD PMID:28329830 NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507 		JBrowse link
G MAFK MAF bZIP transcription factor K multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MAFK mRNA CTD PMID:28329830 NCBI chr 7:1,530,702...1,543,043
Ensembl chr 7:1,530,702...1,543,043 		JBrowse link
G MAP3K2 mitogen-activated protein kinase kinase kinase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MAP3K2 mRNA CTD PMID:28329830 NCBI chr 2:127,298,668...127,388,465
Ensembl chr 2:127,298,668...127,388,465 		JBrowse link
G MAP3K20 mitogen-activated protein kinase kinase kinase 20 increases expression
multiple interactions		 ISO fluoranthene results in increased expression of MAP3K20 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of MAP3K20 mRNA		 CTD PMID:28329830 NCBI chr 2:173,075,517...173,268,015
Ensembl chr 2:173,075,435...173,268,015 		JBrowse link
G MAPK1 mitogen-activated protein kinase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased phosphorylation of and results in increased activity of MAPK1 protein; fluoranthene results in increased phosphorylation of and results in increased activity of MAPK1 protein CTD PMID:28329830 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680 		JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased phosphorylation of and results in increased activity of MAPK3 protein; fluoranthene results in increased phosphorylation of and results in increased activity of MAPK3 protein CTD PMID:28329830 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506 		JBrowse link
G MARF1 meiosis regulator and mRNA stability factor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MARF1 mRNA CTD PMID:28329830 NCBI chr16:15,594,387...15,643,154
Ensembl chr16:15,594,387...15,643,154 		JBrowse link
G MARVELD1 MARVEL domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MARVELD1 mRNA CTD PMID:28329830 NCBI chr10:97,713,730...97,718,150
Ensembl chr10:97,713,173...97,718,150 		JBrowse link
G MAST4 microtubule associated serine/threonine kinase family member 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MAST4 mRNA CTD PMID:28329830 NCBI chr 5:66,596,393...67,169,593
Ensembl chr 5:66,596,380...67,169,593 		JBrowse link
G MBLAC2 metallo-beta-lactamase domain containing 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MBLAC2 mRNA CTD PMID:28329830 NCBI chr 5:90,458,209...90,474,771
Ensembl chr 5:90,458,209...90,474,771 		JBrowse link
G MBOAT1 membrane bound O-acyltransferase domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MBOAT1 mRNA CTD PMID:28329830 NCBI chr 6:20,099,684...20,212,469
Ensembl chr 6:20,099,684...20,212,469 		JBrowse link
G MCC MCC regulator of WNT signaling pathway multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MCC mRNA CTD PMID:28329830 NCBI chr 5:113,022,106...113,488,453
Ensembl chr 5:113,022,106...113,488,823 		JBrowse link
G MDM2 MDM2 proto-oncogene multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of MDM2 mRNA CTD PMID:17690111 NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544 		JBrowse link
G ME1 malic enzyme 1 multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of ME1 mRNA CTD PMID:18711122 NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051 		JBrowse link
G MED13L mediator complex subunit 13L multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MED13L mRNA CTD PMID:28329830 NCBI chr12:115,958,576...116,277,693
Ensembl chr12:115,957,905...116,277,693 		JBrowse link
G MEDAG mesenteric estrogen dependent adipogenesis multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MEDAG mRNA CTD PMID:28329830 NCBI chr13:30,906,271...30,925,572
Ensembl chr13:30,906,271...30,925,572 		JBrowse link
G MEF2D myocyte enhancer factor 2D multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MEF2D mRNA CTD PMID:28329830 NCBI chr 1:156,463,727...156,500,775
Ensembl chr 1:156,463,727...156,500,779 		JBrowse link
G MEIS2 Meis homeobox 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MEIS2 mRNA CTD PMID:28329830 NCBI chr15:36,889,204...37,101,311
Ensembl chr15:36,889,204...37,101,299 		JBrowse link
G MFSD9 major facilitator superfamily domain containing 9 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MFSD9 mRNA CTD PMID:28329830 NCBI chr 2:102,714,630...102,736,888
Ensembl chr 2:102,714,630...102,736,888 		JBrowse link
G MIA2 MIA SH3 domain ER export factor 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MIA2 mRNA CTD PMID:28329830 NCBI chr14:39,233,915...39,388,522
Ensembl chr14:39,230,231...39,388,513 		JBrowse link
G MIDEAS mitotic deacetylase associated SANT domain protein multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MIDEAS mRNA CTD PMID:28329830 NCBI chr14:73,715,122...73,790,285
Ensembl chr14:73,715,122...73,790,285 		JBrowse link
G MIR155 microRNA 155 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MIR155 mRNA CTD PMID:28329830 NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044 		JBrowse link
G MIR22 microRNA 22 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MIR22 mRNA CTD PMID:28329830 NCBI chr17:1,713,903...1,713,987
Ensembl chr17:1,713,903...1,713,987 		JBrowse link
G MMAB metabolism of cobalamin associated B decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of MMAB mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of MMAB mRNA		 CTD PMID:28329830 NCBI chr12:109,553,715...109,573,504
Ensembl chr12:109,553,715...109,573,580 		JBrowse link
G MMD monocyte to macrophage differentiation associated multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MMD mRNA CTD PMID:28329830 NCBI chr17:55,392,622...55,421,835
Ensembl chr17:55,392,622...55,421,924 		JBrowse link
G MMP10 matrix metallopeptidase 10 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MMP10 mRNA CTD PMID:28329830 NCBI chr11:102,770,502...102,780,628
Ensembl chr11:102,770,502...102,780,628 		JBrowse link
G MMP13 matrix metallopeptidase 13 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MMP13 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of MMP13 mRNA] CTD PMID:28329830 NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732 		JBrowse link
G MMP28 matrix metallopeptidase 28 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MMP28 mRNA CTD PMID:28329830 NCBI chr17:35,756,249...35,795,641
Ensembl chr17:35,756,249...35,795,707 		JBrowse link
G MMP3 matrix metallopeptidase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MMP3 mRNA CTD PMID:28329830 NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609 		JBrowse link
G MNDA myeloid cell nuclear differentiation antigen multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MNDA mRNA CTD PMID:28329830 NCBI chr 1:158,831,351...158,849,502
Ensembl chr 1:158,831,351...158,849,506 		JBrowse link
G MNT MAX network transcriptional repressor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MNT mRNA CTD PMID:28329830 NCBI chr17:2,384,073...2,401,060
Ensembl chr17:2,384,073...2,401,104 		JBrowse link
G MOSPD3 motile sperm domain containing 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MOSPD3 mRNA CTD PMID:28329830 NCBI chr 7:100,612,162...100,615,377
Ensembl chr 7:100,612,102...100,615,384 		JBrowse link
G MOV10 Mov10 RNA helicase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MOV10 mRNA CTD PMID:28329830 NCBI chr 1:112,674,439...112,700,739
Ensembl chr 1:112,673,141...112,700,756 		JBrowse link
G MPP2 MAGUK p55 scaffold protein 2 multiple interactions
increases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MPP2 mRNA
fluoranthene results in increased expression of MPP2 mRNA		 CTD PMID:28329830 NCBI chr17:43,875,360...43,909,711
Ensembl chr17:43,875,357...43,909,711 		JBrowse link
G MPV17L2 MPV17 mitochondrial inner membrane protein like 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MPV17L2 mRNA CTD PMID:28329830 NCBI chr19:18,193,218...18,196,948
Ensembl chr19:18,193,218...18,196,948 		JBrowse link
G MRPL28 mitochondrial ribosomal protein L28 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MRPL28 mRNA CTD PMID:28329830 NCBI chr16:366,969...370,538
Ensembl chr16:366,969...371,289 		JBrowse link
G MRPL36 mitochondrial ribosomal protein L36 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MRPL36 mRNA CTD PMID:28329830 NCBI chr 5:1,798,385...1,801,434
Ensembl chr 5:1,798,385...1,801,366 		JBrowse link
G MRPL51 mitochondrial ribosomal protein L51 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MRPL51 mRNA CTD PMID:28329830 NCBI chr12:6,491,886...6,493,262
Ensembl chr12:6,491,886...6,493,841 		JBrowse link
G MSMO1 methylsterol monooxygenase 1 decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of MSMO1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of MSMO1 mRNA		 CTD PMID:28329830 NCBI chr 4:165,327,669...165,343,164
Ensembl chr 4:165,327,667...165,343,164 		JBrowse link
G MTCL3 MTCL family member 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MTCL3 mRNA CTD PMID:28329830 NCBI chr 6:127,472,974...127,519,335
Ensembl chr 6:127,472,806...127,519,335 		JBrowse link
G MTHFD2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MTHFD2 mRNA CTD PMID:28329830 NCBI chr 2:74,198,615...74,217,565
Ensembl chr 2:74,186,172...74,217,565 		JBrowse link
G MTMR10 myotubularin related protein 10 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MTMR10 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of MTMR10 mRNA] CTD PMID:28329830 NCBI chr15:30,918,716...30,991,628
Ensembl chr15:30,938,941...30,991,628 		JBrowse link
G MUC2 mucin 2, oligomeric mucus/gel-forming multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MUC2 mRNA CTD PMID:28329830 NCBI chr11:1,074,874...1,110,508
Ensembl chr11:1,074,875...1,110,511 		JBrowse link
G MUC5AC mucin 5AC, oligomeric mucus/gel-forming increases expression EXP fluoranthene results in increased expression of MUC5AC mRNA; fluoranthene results in increased expression of MUC5AC protein CTD PMID:29787794 NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138 		JBrowse link
G MUC6 mucin 6, oligomeric mucus/gel-forming increases expression ISO fluoranthene results in increased expression of MUC6 mRNA CTD PMID:28329830 NCBI chr11:1,012,823...1,036,718
Ensembl chr11:1,012,823...1,036,718 		JBrowse link
G MVD mevalonate diphosphate decarboxylase decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of MVD mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of MVD mRNA		 CTD PMID:28329830 NCBI chr16:88,651,940...88,663,091
Ensembl chr16:88,651,935...88,663,161 		JBrowse link
G MVK mevalonate kinase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MVK mRNA CTD PMID:28329830 NCBI chr12:109,573,272...109,598,125
Ensembl chr12:109,573,255...109,598,125 		JBrowse link
G MXRA7 matrix remodeling associated 7 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MXRA7 mRNA CTD PMID:28329830 NCBI chr17:76,672,551...76,710,965
Ensembl chr17:76,672,551...76,711,004 		JBrowse link
G MYC MYC proto-oncogene, bHLH transcription factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MYC mRNA CTD PMID:28329830 NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951 		JBrowse link
G MYH6 myosin heavy chain 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of MYH6 mRNA CTD PMID:28329830 NCBI chr14:23,381,987...23,408,273
Ensembl chr14:23,381,982...23,408,273 		JBrowse link
G MYL12B myosin light chain 12B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MYL12B mRNA CTD PMID:28329830 NCBI chr18:3,262,133...3,278,461
Ensembl chr18:3,261,479...3,278,461 		JBrowse link
G NAPEPLD N-acyl phosphatidylethanolamine phospholipase D multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of NAPEPLD mRNA CTD PMID:28329830 NCBI chr 7:103,099,776...103,150,001
Ensembl chr 7:103,099,776...103,149,560 		JBrowse link
G NARF nuclear prelamin A recognition factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of NARF mRNA CTD PMID:28329830 NCBI chr17:82,458,198...82,490,537
Ensembl chr17:82,458,180...82,490,537 		JBrowse link
G NCS1 neuronal calcium sensor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of NCS1 mRNA CTD PMID:28329830 NCBI chr 9:130,172,404...130,237,303
Ensembl chr 9:130,172,404...130,237,303 		JBrowse link
G NDE1 nudE neurodevelopment protein 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of NDE1 mRNA CTD PMID:28329830 NCBI chr16:15,643,382...15,726,353
Ensembl chr16:15,643,267...15,734,691 		JBrowse link
G NDEL1 nudE neurodevelopment protein 1 like 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NDEL1 mRNA CTD PMID:28329830 NCBI chr17:8,413,131...8,474,328
Ensembl chr17:8,413,131...8,490,411 		JBrowse link
G NDRG1 N-myc downstream regulated 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NDRG1 mRNA CTD PMID:28329830 NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022 		JBrowse link
G NEAT1 nuclear paraspeckle assembly transcript 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NEAT1 mRNA CTD PMID:28329830 NCBI chr11:65,422,798...65,445,540
Ensembl chr11:65,422,774...65,445,540 		JBrowse link
G NEDD4L NEDD4 like E3 ubiquitin protein ligase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NEDD4L mRNA CTD PMID:28329830 NCBI chr18:58,044,226...58,401,540
Ensembl chr18:58,044,226...58,401,540 		JBrowse link
G NEURL3 neuralized E3 ubiquitin protein ligase 3 multiple interactions
increases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NEURL3 mRNA
fluoranthene results in increased expression of NEURL3 mRNA		 CTD PMID:28329830 NCBI chr 2:96,497,646...96,508,109
Ensembl chr 2:96,497,646...96,508,109 		JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NFE2L2 mRNA CTD PMID:28329830 NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756 		JBrowse link
G NFIL3 nuclear factor, interleukin 3 regulated multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NFIL3 mRNA CTD PMID:28329830 NCBI chr 9:91,409,045...91,483,497
Ensembl chr 9:91,409,045...91,423,832 		JBrowse link
G NFKB2 nuclear factor kappa B subunit 2 multiple interactions ISO
EXP		 [1-methylanthracene co-treated with fluoranthene] results in increased expression of NFKB2 mRNA
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of NFKB2 protein		 CTD PMID:28329830 PMID:30980910 NCBI chr10:102,394,110...102,402,529
Ensembl chr10:102,394,110...102,402,524 		JBrowse link
G NFKBIE NFKB inhibitor epsilon multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NFKBIE mRNA CTD PMID:28329830 NCBI chr 6:44,258,166...44,265,551
Ensembl chr 6:44,258,166...44,265,788 		JBrowse link
G NFKBIZ NFKB inhibitor zeta multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NFKBIZ mRNA CTD PMID:28329830 NCBI chr 3:101,827,990...101,861,022
Ensembl chr 3:101,827,991...101,861,022 		JBrowse link
G NFYB nuclear transcription factor Y subunit beta decreases expression ISO fluoranthene results in decreased expression of NFYB mRNA CTD PMID:28329830 NCBI chr12:104,117,086...104,138,210
Ensembl chr12:104,117,086...104,138,241 		JBrowse link
G NHERF1 NHERF family PDZ scaffold protein 1 decreases expression ISO fluoranthene results in decreased expression of NHERF1 mRNA CTD PMID:28329830 NCBI chr17:74,748,628...74,769,353
Ensembl chr17:74,748,628...74,769,353 		JBrowse link
G NHS NHS actin remodeling regulator multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NHS mRNA CTD PMID:28329830 NCBI chr  X:17,375,200...17,735,994
Ensembl chr  X:17,375,200...17,735,994 		JBrowse link
G NKAIN1 sodium/potassium transporting ATPase interacting 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of NKAIN1 mRNA CTD PMID:28329830 NCBI chr 1:31,179,745...31,239,887
Ensembl chr 1:31,179,745...31,239,887 		JBrowse link
G NMD3 NMD3 ribosome export adaptor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NMD3 mRNA CTD PMID:28329830 NCBI chr 3:161,221,102...161,253,532
Ensembl chr 3:161,104,696...161,253,532 		JBrowse link
G NOL8 nucleolar protein 8 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NOL8 mRNA CTD PMID:28329830 NCBI chr 9:92,297,358...92,325,350
Ensembl chr 9:92,297,358...92,325,636 		JBrowse link
G NOP58 NOP58 ribonucleoprotein multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NOP58 mRNA CTD PMID:28329830 NCBI chr 2:202,265,763...202,303,661
Ensembl chr 2:202,265,736...202,303,661 		JBrowse link
G NOS3 nitric oxide synthase 3 multiple interactions
increases expression		 EXP 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [fluoranthene results in increased expression of NOS3 mRNA]; 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [fluoranthene results in increased expression of NOS3 protein]; nickel chloride inhibits the reaction [fluoranthene results in increased expression of NOS3 protein]; Proadifen inhibits the reaction [fluoranthene results in increased expression of NOS3 protein]
fluoranthene results in increased expression of NOS3 mRNA; fluoranthene results in increased expression of NOS3 protein		 CTD PMID:15183461 NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588 		JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 multiple interactions
increases expression		 ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of NQO1 mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of NQO1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of NQO1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of NQO1 mRNA]
fluoranthene results in increased expression of NQO1 mRNA		 CTD PMID:18711122 PMID:28329830 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668 		JBrowse link
G NQO2 N-ribosyldihydronicotinamide:quinone dehydrogenase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of NQO2 mRNA CTD PMID:28329830 NCBI chr 6:2,999,894...3,019,755
Ensembl chr 6:2,987,987...3,019,755 		JBrowse link
G NR1D1 nuclear receptor subfamily 1 group D member 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NR1D1 mRNA CTD PMID:28329830 NCBI chr17:40,092,793...40,100,589
Ensembl chr17:40,092,793...40,100,589 		JBrowse link
G NR1D2 nuclear receptor subfamily 1 group D member 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NR1D2 mRNA CTD PMID:28329830 NCBI chr 3:23,945,286...23,980,617
Ensembl chr 3:23,945,286...23,980,617 		JBrowse link
G NR1H4 nuclear receptor subfamily 1 group H member 4 increases expression
multiple interactions		 ISO fluoranthene results in increased expression of NR1H4 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of NR1H4 mRNA		 CTD PMID:28329830 NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414 		JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 multiple interactions EXP
ISO		 fluoranthene binds to and results in increased activity of NR1I2 protein CTD PMID:33049310 NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487 		JBrowse link
G NR1I3 nuclear receptor subfamily 1 group I member 3 increases activity
increases expression
multiple interactions		 EXP fluoranthene results in increased activity of NR1I3 protein
fluoranthene results in increased expression of NR1I3 mRNA
[Benzo(a)pyrene co-treated with fluoranthene] inhibits the reaction [pyrene results in increased expression of NR1I3 mRNA]; [Benzo(a)pyrene co-treated with pyrene] inhibits the reaction [fluoranthene results in increased expression of NR1I3 mRNA]; Benzo(a)pyrene inhibits the reaction [fluoranthene results in increased expression of NR1I3 mRNA]; fluoranthene inhibits the reaction [pyrene results in increased expression of NR1I3 mRNA]; pyrene inhibits the reaction [fluoranthene results in increased expression of NR1I3 mRNA]		 CTD PMID:28927721 PMID:33249052 NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244 		JBrowse link
G NR3C1 nuclear receptor subfamily 3 group C member 1 multiple interactions
increases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NR3C1 mRNA
fluoranthene results in increased expression of NR3C1 mRNA		 CTD PMID:28329830 NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512 		JBrowse link
G NR4A1 nuclear receptor subfamily 4 group A member 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NR4A1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of NR4A1 mRNA] CTD PMID:28329830 NCBI chr12:52,022,832...52,059,503
Ensembl chr12:52,022,832...52,059,507 		JBrowse link
G NR4A2 nuclear receptor subfamily 4 group A member 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NR4A2 mRNA CTD PMID:28329830 NCBI chr 2:156,324,437...156,332,721
Ensembl chr 2:156,324,437...156,342,348 		JBrowse link
G NR4A3 nuclear receptor subfamily 4 group A member 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NR4A3 mRNA CTD PMID:28329830 NCBI chr 9:99,821,885...99,866,891
Ensembl chr 9:99,821,855...99,866,891 		JBrowse link
G NRG1 neuregulin 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NRG1 mRNA CTD PMID:28329830 NCBI chr 8:31,639,245...32,774,046
Ensembl chr 8:31,639,222...32,855,666 		JBrowse link
G NSDHL NAD(P) dependent steroid dehydrogenase-like multiple interactions
decreases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of NSDHL mRNA
fluoranthene results in decreased expression of NSDHL mRNA		 CTD PMID:28329830 NCBI chr  X:152,831,063...152,869,729
Ensembl chr  X:152,830,967...152,869,729 		JBrowse link
G NT5DC3 5'-nucleotidase domain containing 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of NT5DC3 mRNA CTD PMID:28329830 NCBI chr12:103,746,315...103,841,234
Ensembl chr12:103,770,453...103,841,234 		JBrowse link
G NUDT16L1 nudix hydrolase 16 like 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of NUDT16L1 mRNA CTD PMID:28329830 NCBI chr16:4,693,562...4,695,859
Ensembl chr16:4,693,562...4,695,859 		JBrowse link
G NUP58 nucleoporin 58 multiple interactions ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of NUP58 mRNA CTD PMID:18711122 NCBI chr13:25,301,625...25,349,800
Ensembl chr13:25,301,524...25,365,390 		JBrowse link
G NUPR1 nuclear protein 1, transcriptional regulator multiple interactions ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of NUPR1 mRNA CTD PMID:18711122 NCBI chr16:28,532,708...28,538,974
Ensembl chr16:28,532,708...28,539,008 		JBrowse link
G OAZ2 ornithine decarboxylase antizyme 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of OAZ2 mRNA CTD PMID:28329830 NCBI chr15:64,687,574...64,703,281
Ensembl chr15:64,687,573...64,703,281 		JBrowse link
G OGFRL1 opioid growth factor receptor like 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of OGFRL1 mRNA CTD PMID:28329830 NCBI chr 6:71,288,811...71,309,059
Ensembl chr 6:71,288,811...71,309,059 		JBrowse link
G OLR1 oxidized low density lipoprotein receptor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of OLR1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of OLR1 mRNA] CTD PMID:28329830 NCBI chr12:10,158,301...10,176,266
Ensembl chr12:10,158,301...10,172,138 		JBrowse link
G OMA1 OMA1 zinc metallopeptidase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of OMA1 mRNA CTD PMID:28329830 NCBI chr 1:58,480,719...58,546,726
Ensembl chr 1:58,415,384...58,546,802 		JBrowse link
G OR51I2 olfactory receptor family 51 subfamily I member 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of OR51I2 mRNA CTD PMID:28329830 NCBI chr11:5,449,323...5,456,518
Ensembl chr11:5,449,323...5,456,518 		JBrowse link
G ORMDL1 ORMDL sphingolipid biosynthesis regulator 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ORMDL1 mRNA CTD PMID:28329830 NCBI chr 2:189,763,859...189,784,339
Ensembl chr 2:189,770,267...189,784,364 		JBrowse link
G ORMDL2 ORMDL sphingolipid biosynthesis regulator 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ORMDL2 mRNA CTD PMID:28329830 NCBI chr12:55,818,041...55,821,879
Ensembl chr12:55,818,041...55,821,879 		JBrowse link
G OSBPL2 oxysterol binding protein like 2 increases expression
multiple interactions		 ISO fluoranthene results in increased expression of OSBPL2 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of OSBPL2 mRNA		 CTD PMID:28329830 NCBI chr20:62,228,243...62,236,301
Ensembl chr20:62,231,922...62,296,213 		JBrowse link
G OSER1 oxidative stress responsive serine rich 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of OSER1 mRNA CTD PMID:28329830 NCBI chr20:44,195,939...44,211,810
Ensembl chr20:44,195,939...44,210,771 		JBrowse link
G OSGIN1 oxidative stress induced growth inhibitor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of OSGIN1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of OSGIN1 mRNA] CTD PMID:28329830 NCBI chr16:83,953,240...83,966,332
Ensembl chr16:83,931,311...83,966,332 		JBrowse link
G OSMR oncostatin M receptor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of OSMR mRNA CTD PMID:28329830 NCBI chr 5:38,846,012...38,945,579
Ensembl chr 5:38,845,858...38,945,596 		JBrowse link
G P4HA2 prolyl 4-hydroxylase subunit alpha 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of P4HA2 mRNA CTD PMID:28329830 NCBI chr 5:132,190,147...132,227,853
Ensembl chr 5:132,190,147...132,295,315 		JBrowse link
G PAQR3 progestin and adipoQ receptor family member 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PAQR3 mRNA CTD PMID:28329830 NCBI chr 4:78,887,076...78,939,438
Ensembl chr 4:78,887,127...78,939,438 		JBrowse link
G PARP1 poly(ADP-ribose) polymerase 1 increases cleavage EXP fluoranthene results in increased cleavage of PARP1 protein CTD PMID:21132278 NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154 		JBrowse link
G PARS2 prolyl-tRNA synthetase 2, mitochondrial multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PARS2 mRNA CTD PMID:28329830 NCBI chr 1:54,756,898...54,764,523
Ensembl chr 1:54,756,898...54,764,523 		JBrowse link
G PAWR pro-apoptotic WT1 regulator multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PAWR mRNA CTD PMID:28329830 NCBI chr12:79,584,879...79,690,964
Ensembl chr12:79,574,979...79,690,964 		JBrowse link
G PCBD2 pterin-4 alpha-carbinolamine dehydratase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PCBD2 mRNA CTD PMID:28329830 NCBI chr 5:134,905,131...134,962,644
Ensembl chr 5:134,905,120...135,007,959 		JBrowse link
G PCDHB16 protocadherin beta 16 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PCDHB16 mRNA CTD PMID:28329830 NCBI chr 5:141,182,387...141,186,226
Ensembl chr 5:141,182,387...141,186,226 		JBrowse link
G PDK1 pyruvate dehydrogenase kinase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PDK1 mRNA CTD PMID:28329830 NCBI chr 2:172,555,373...172,724,312
Ensembl chr 2:172,555,373...172,608,669 		JBrowse link
G PER1 period circadian regulator 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PER1 mRNA CTD PMID:28329830 NCBI chr17:8,140,472...8,152,404
Ensembl chr17:8,140,472...8,156,506 		JBrowse link
G PER2 period circadian regulator 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PER2 mRNA CTD PMID:28329830 NCBI chr 2:238,244,044...238,300,065
Ensembl chr 2:238,244,044...238,290,102 		JBrowse link
G PFKFB1 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of PFKFB1 mRNA CTD PMID:18711122 NCBI chr  X:54,932,961...54,998,789
Ensembl chr  X:54,932,961...54,998,534 		JBrowse link
G PFKL phosphofructokinase, liver type multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PFKL mRNA CTD PMID:28329830 NCBI chr21:44,300,053...44,327,373
Ensembl chr21:44,300,051...44,327,376 		JBrowse link
G PGAM1 phosphoglycerate mutase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PGAM1 mRNA CTD PMID:28329830 NCBI chr10:97,426,191...97,433,444
Ensembl chr10:97,426,191...97,433,444 		JBrowse link
G PGM2 phosphoglucomutase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PGM2 mRNA CTD PMID:28329830 NCBI chr 4:37,826,686...37,862,937
Ensembl chr 4:37,826,660...37,862,937 		JBrowse link
G PGP phosphoglycolate phosphatase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PGP mRNA CTD PMID:28329830 NCBI chr16:2,211,593...2,214,840
Ensembl chr16:2,211,593...2,214,840 		JBrowse link
G PHLDA1 pleckstrin homology like domain family A member 1 multiple interactions
increases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PHLDA1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of PHLDA1 mRNA]
fluoranthene results in increased expression of PHLDA1 mRNA		 CTD PMID:28329830 NCBI chr12:76,025,447...76,031,776
Ensembl chr12:76,025,447...76,031,776 		JBrowse link
G PI4K2B phosphatidylinositol 4-kinase type 2 beta multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PI4K2B mRNA CTD PMID:28329830 NCBI chr 4:25,234,033...25,279,204
Ensembl chr 4:25,160,663...25,279,204 		JBrowse link
G PIM3 Pim-3 proto-oncogene, serine/threonine kinase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PIM3 mRNA CTD PMID:28329830 NCBI chr22:49,960,772...49,964,072
Ensembl chr22:49,960,768...49,964,072 		JBrowse link
G PIP4K2B phosphatidylinositol-5-phosphate 4-kinase type 2 beta multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PIP4K2B mRNA CTD PMID:28329830 NCBI chr17:38,765,691...38,799,556
Ensembl chr17:38,765,691...38,800,126 		JBrowse link
G PITPNC1 phosphatidylinositol transfer protein cytoplasmic 1 multiple interactions
increases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PITPNC1 mRNA
fluoranthene results in increased expression of PITPNC1 mRNA		 CTD PMID:28329830 NCBI chr17:67,377,281...67,697,256
Ensembl chr17:67,377,281...67,697,256 		JBrowse link
G PLA2G4A phospholipase A2 group IVA multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PLA2G4A mRNA; [1-methylanthracene co-treated with fluoranthene] results in increased phosphorylation of and results in increased activity of PLA2G4A protein CTD PMID:28329830 PMID:30690640 NCBI chr 1:186,828,949...186,988,981
Ensembl chr 1:186,828,949...186,988,981 		JBrowse link
G PLAUR plasminogen activator, urokinase receptor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PLAUR mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of PLAUR mRNA] CTD PMID:28329830 NCBI chr19:43,646,095...43,670,169
Ensembl chr19:43,646,095...43,670,547 		JBrowse link
G PLCD3 phospholipase C delta 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PLCD3 mRNA CTD PMID:28329830 NCBI chr17:45,108,959...45,132,515
Ensembl chr17:45,108,959...45,133,354 		JBrowse link
G PLCL2 phospholipase C like 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PLCL2 mRNA CTD PMID:28329830 NCBI chr 3:16,884,955...17,090,606
Ensembl chr 3:16,802,651...17,090,604 		JBrowse link
G PLEKHA2 pleckstrin homology domain containing A2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PLEKHA2 mRNA CTD PMID:28329830 NCBI chr 8:38,901,346...38,973,912
Ensembl chr 8:38,901,235...38,973,912 		JBrowse link
G PLEKHF1 pleckstrin homology and FYVE domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PLEKHF1 mRNA CTD PMID:28329830 NCBI chr19:29,665,461...29,675,477
Ensembl chr19:29,665,459...29,675,477 		JBrowse link
G PLK2 polo like kinase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PLK2 mRNA CTD PMID:28329830 NCBI chr 5:58,453,982...58,460,086
Ensembl chr 5:58,453,982...58,460,139 		JBrowse link
G PLK3 polo like kinase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PLK3 mRNA CTD PMID:28329830 NCBI chr 1:44,800,377...44,805,990
Ensembl chr 1:44,800,377...44,805,990 		JBrowse link
G PLPP1 phospholipid phosphatase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PPAP2A mRNA CTD PMID:28329830 NCBI chr 5:55,424,854...55,534,964
Ensembl chr 5:55,424,854...55,534,969 		JBrowse link
G PML PML nuclear body scaffold multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PML mRNA CTD PMID:28329830 NCBI chr15:73,994,716...74,047,827
Ensembl chr15:73,994,673...74,047,827 		JBrowse link
G PNRC2 proline rich nuclear receptor coactivator 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PNRC2 mRNA CTD PMID:28329830 NCBI chr 1:23,959,164...23,963,462
Ensembl chr 1:23,956,839...23,963,462 		JBrowse link
G POLR2D RNA polymerase II subunit D multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of POLR2D mRNA CTD PMID:28329830 NCBI chr 2:127,843,553...127,858,155
Ensembl chr 2:127,843,553...127,858,155 		JBrowse link
G POLR3D RNA polymerase III subunit D multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of POLR3D mRNA CTD PMID:28329830 NCBI chr 8:22,245,133...22,254,601
Ensembl chr 8:22,245,133...22,254,601 		JBrowse link
G POLR3G RNA polymerase III subunit G multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of POLR3G mRNA CTD PMID:28329830 NCBI chr 5:90,473,929...90,514,557
Ensembl chr 5:90,471,748...90,514,557 		JBrowse link
G POMGNT2 protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-) multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of POMGNT2 mRNA CTD PMID:28329830 NCBI chr 3:43,079,234...43,106,079
Ensembl chr 3:43,079,229...43,106,085 		JBrowse link
G POMK protein O-mannose kinase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of POMK mRNA CTD PMID:28329830 NCBI chr 8:43,093,515...43,123,434
Ensembl chr 8:43,093,498...43,131,180 		JBrowse link
G PPAN peter pan homolog multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PPAN mRNA CTD PMID:28329830 NCBI chr19:10,106,223...10,112,012
Ensembl chr19:10,106,362...10,112,012 		JBrowse link
G PPARD peroxisome proliferator activated receptor delta multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PPARD mRNA CTD PMID:28329830 NCBI chr 6:35,342,558...35,428,178
Ensembl chr 6:35,342,558...35,428,191 		JBrowse link
G PPARG peroxisome proliferator activated receptor gamma multiple interactions EXP fluoranthene binds to and results in increased activity of PPARG protein CTD PMID:33049310 NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356 		JBrowse link
G PPP1R15A protein phosphatase 1 regulatory subunit 15A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PPP1R15A mRNA CTD PMID:28329830 NCBI chr19:48,872,421...48,876,058
Ensembl chr19:48,872,212...48,876,059 		JBrowse link
G PPP1R3B protein phosphatase 1 regulatory subunit 3B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PPP1R3B mRNA CTD PMID:28329830 NCBI chr 8:9,136,255...9,151,539
Ensembl chr 8:9,136,255...9,151,574 		JBrowse link
G PPRC1 PPARG related coactivator 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PPRC1 mRNA CTD PMID:28329830 NCBI chr10:102,119,889...102,150,333
Ensembl chr10:102,132,994...102,150,333 		JBrowse link
G PRELID1 PRELI domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PRELID1 mRNA CTD PMID:28329830 NCBI chr 5:177,303,799...177,306,949
Ensembl chr 5:177,303,799...177,306,949 		JBrowse link
G PRELP proline and arginine rich end leucine rich repeat protein multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PRELP mRNA CTD PMID:28329830 NCBI chr 1:203,475,806...203,491,352
Ensembl chr 1:203,475,806...203,491,352 		JBrowse link
G PRKACA protein kinase cAMP-activated catalytic subunit alpha multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PRKACA mRNA CTD PMID:28329830 NCBI chr19:14,091,688...14,117,762
Ensembl chr19:14,091,688...14,118,084 		JBrowse link
G PTGR1 prostaglandin reductase 1 multiple interactions ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of PTGR1 mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of PTGR1 mRNA CTD PMID:18711122 NCBI chr 9:111,549,722...111,599,647
Ensembl chr 9:111,549,722...111,599,893 		JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression		 ISO [1-methylanthracene co-treated with fluoranthene] promotes the reaction [Benzo(a)pyrene results in increased expression of PTGS2 mRNA]; [1-methylanthracene co-treated with fluoranthene] results in increased expression of PTGS2 mRNA; [1-methylanthracene co-treated with fluoranthene] results in increased expression of PTGS2 protein; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of PTGS2 mRNA]
fluoranthene results in increased expression of PTGS2 mRNA		 CTD PMID:28329830 PMID:29170806 PMID:30690640 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922 		JBrowse link
G PTPN2 protein tyrosine phosphatase non-receptor type 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PTPN2 mRNA CTD PMID:28329830 NCBI chr18:12,785,478...12,884,237
Ensembl chr18:12,785,478...12,929,643 		JBrowse link
G PTPN22 protein tyrosine phosphatase non-receptor type 22 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PTPN22 mRNA CTD PMID:28329830 NCBI chr 1:113,813,811...113,871,759
Ensembl chr 1:113,813,811...113,871,753 		JBrowse link
G PTPRE protein tyrosine phosphatase receptor type E multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PTPRE mRNA CTD PMID:28329830 NCBI chr10:127,907,103...128,085,855
Ensembl chr10:127,907,103...128,085,855 		JBrowse link
G PTX3 pentraxin 3 increases expression
multiple interactions		 ISO fluoranthene results in increased expression of PTX3 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of PTX3 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of PTX3 mRNA]		 CTD PMID:28329830 NCBI chr 3:157,436,850...157,443,633
Ensembl chr 3:157,436,850...157,443,633 		JBrowse link
G PVR PVR cell adhesion molecule multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PVR mRNA CTD PMID:28329830 NCBI chr19:44,643,910...44,666,162
Ensembl chr19:44,643,798...44,666,162 		JBrowse link
G PXDC1 PX domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of PXDC1 mRNA CTD PMID:28329830 NCBI chr 6:3,722,619...3,751,713
Ensembl chr 6:3,722,614...3,751,713 		JBrowse link
G PXDN peroxidasin multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PXDN mRNA CTD PMID:28329830 NCBI chr 2:1,631,887...1,744,901
Ensembl chr 2:1,631,887...1,744,852 		JBrowse link
G QPCTL glutaminyl-peptide cyclotransferase like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of QPCTL mRNA CTD PMID:28329830 NCBI chr19:45,692,666...45,703,987
Ensembl chr19:45,692,403...45,703,989 		JBrowse link
G QTRT2 queuine tRNA-ribosyltransferase accessory subunit 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of QTRT2 mRNA CTD PMID:28329830 NCBI chr 3:114,056,737...114,088,422
Ensembl chr 3:114,005,833...114,088,422 		JBrowse link
G RAB1B RAB1B, member RAS oncogene family multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of RAB1B mRNA CTD PMID:28329830 NCBI chr11:66,268,639...66,277,492
Ensembl chr11:66,268,590...66,277,492 		JBrowse link
G RAB20 RAB20, member RAS oncogene family multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RAB20 mRNA CTD PMID:28329830 NCBI chr13:110,523,066...110,561,722
Ensembl chr13:110,523,066...110,561,722 		JBrowse link
G RAB29 RAB29, member RAS oncogene family multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of RAB29 mRNA CTD PMID:28329830 NCBI chr 1:205,767,986...205,775,482
Ensembl chr 1:205,767,986...205,775,482 		JBrowse link
G RAB3D RAB3D, member RAS oncogene family multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of RAB3D mRNA CTD PMID:28329830 NCBI chr19:11,322,068...11,339,657
Ensembl chr19:11,322,068...11,346,270 		JBrowse link
G RABGGTB Rab geranylgeranyltransferase subunit beta multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RABGGTB mRNA CTD PMID:28329830 NCBI chr 1:75,786,194...75,795,090
Ensembl chr 1:75,786,197...75,795,086 		JBrowse link
G RANBP9 RAN binding protein 9 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RANBP9 mRNA CTD PMID:28329830 NCBI chr 6:13,621,498...13,711,835
Ensembl chr 6:13,621,498...13,711,835 		JBrowse link
G RAPGEF2 Rap guanine nucleotide exchange factor 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RAPGEF2 mRNA CTD PMID:28329830 NCBI chr 4:159,103,079...159,360,173
Ensembl chr 4:159,103,013...159,360,174 		JBrowse link
G RASGEF1B RasGEF domain family member 1B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RASGEF1B mRNA CTD PMID:28329830 NCBI chr 4:81,426,393...81,471,907
Ensembl chr 4:81,426,393...82,044,244 		JBrowse link
G RASSF1 Ras association domain family member 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RASSF1 mRNA CTD PMID:28329830 NCBI chr 3:50,329,788...50,340,836
Ensembl chr 3:50,329,782...50,340,980 		JBrowse link
G RASSF3 Ras association domain family member 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of RASSF3 mRNA CTD PMID:28329830 NCBI chr12:64,506,964...64,697,564
Ensembl chr12:64,507,001...64,697,564 		JBrowse link
G RASSF8 Ras association domain family member 8 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RASSF8 mRNA CTD PMID:28329830 NCBI chr12:25,958,232...26,079,889
Ensembl chr12:25,958,232...26,079,892 		JBrowse link
G RBM33 RNA binding motif protein 33 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RBM33 mRNA CTD PMID:28329830 NCBI chr 7:155,644,661...155,781,480
Ensembl chr 7:155,644,451...155,781,485 		JBrowse link
G RDH11 retinol dehydrogenase 11 decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of RDH11 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of RDH11 mRNA		 CTD PMID:28329830 NCBI chr14:67,676,800...67,695,764
Ensembl chr14:67,676,800...67,695,793 		JBrowse link
G RECK reversion inducing cysteine rich protein with kazal motifs multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of RECK mRNA CTD PMID:28329830 NCBI chr 9:36,036,913...36,124,455
Ensembl chr 9:36,036,913...36,124,455 		JBrowse link
G REEP6 receptor accessory protein 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of REEP6 mRNA CTD PMID:28329830 NCBI chr19:1,491,181...1,497,927
Ensembl chr19:1,491,166...1,497,927 		JBrowse link
G RELB RELB proto-oncogene, NF-kB subunit multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RELB mRNA CTD PMID:28329830 NCBI chr19:45,001,464...45,038,192
Ensembl chr19:45,001,461...45,038,192 		JBrowse link
G RFLNB refilin B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of RFLNB mRNA CTD PMID:28329830 NCBI chr17:439,978...445,940
Ensembl chr17:439,978...445,939 		JBrowse link
G RHBDD2 rhomboid domain containing 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of RHBDD2 mRNA CTD PMID:28329830 NCBI chr 7:75,879,034...75,888,926
Ensembl chr 7:75,842,602...75,888,926 		JBrowse link
G RHBDF2 rhomboid 5 homolog 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RHBDF2 mRNA CTD PMID:28329830 NCBI chr17:76,470,893...76,501,427
Ensembl chr17:76,470,891...76,501,790 		JBrowse link
G RHOB ras homolog family member B decreases expression ISO fluoranthene results in decreased expression of RHOB mRNA CTD PMID:28329830 NCBI chr 2:20,447,074...20,449,440
Ensembl chr 2:20,447,074...20,449,440 		JBrowse link
G RHPN2 rhophilin Rho GTPase binding protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RHPN2 mRNA CTD PMID:28329830 NCBI chr19:32,978,592...33,064,888
Ensembl chr19:32,978,592...33,064,888 		JBrowse link
G RIPK2 receptor interacting serine/threonine kinase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RIPK2 mRNA CTD PMID:28329830 NCBI chr 8:89,757,816...89,791,064
Ensembl chr 8:89,757,806...89,791,064 		JBrowse link
G RND1 Rho family GTPase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RND1 mRNA CTD PMID:28329830 NCBI chr12:48,857,145...48,865,870
Ensembl chr12:48,857,145...48,865,870 		JBrowse link
G RND3 Rho family GTPase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RND3 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of RND3 mRNA] CTD PMID:28329830 NCBI chr 2:150,468,193...150,487,695
Ensembl chr 2:150,468,195...150,539,011 		JBrowse link
G RNF125 ring finger protein 125 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RNF125 mRNA CTD PMID:28329830 NCBI chr18:32,018,825...32,088,144
Ensembl chr18:32,018,825...32,073,219 		JBrowse link
G RNF19B ring finger protein 19B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RNF19B mRNA CTD PMID:28329830 NCBI chr 1:32,929,036...32,964,809
Ensembl chr 1:32,936,445...32,964,809 		JBrowse link
G RNF217 ring finger protein 217 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RNF217 mRNA CTD PMID:28329830 NCBI chr 6:124,962,437...125,092,634
Ensembl chr 6:124,962,437...125,092,633 		JBrowse link
G RNU11 RNA, U11 small nuclear multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RNU11 mRNA CTD PMID:28329830 NCBI chr 1:28,648,600...28,648,734
Ensembl chr 1:28,648,600...28,648,733 		JBrowse link
G RORA RAR related orphan receptor A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RORA mRNA CTD PMID:28329830 NCBI chr15:60,488,284...61,229,302
Ensembl chr15:60,488,284...61,229,302 		JBrowse link
G RPP38 ribonuclease P/MRP subunit p38 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RPP38 mRNA CTD PMID:28329830 NCBI chr10:15,097,355...15,104,257
Ensembl chr10:15,097,180...15,139,818 		JBrowse link
G RRAD RRAD, Ras related glycolysis inhibitor and calcium channel regulator multiple interactions ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of RRAD mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of RRAD mRNA CTD PMID:18711122 NCBI chr16:66,921,685...66,925,535
Ensembl chr16:66,921,685...66,925,535 		JBrowse link
G RUSC2 RUN and SH3 domain containing 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of RUSC2 mRNA CTD PMID:28329830 NCBI chr 9:35,490,111...35,561,895
Ensembl chr 9:35,490,111...35,561,898 		JBrowse link
G S100A16 S100 calcium binding protein A16 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of S100A16 mRNA CTD PMID:28329830 NCBI chr 1:153,606,883...153,613,137
Ensembl chr 1:153,606,886...153,613,145 		JBrowse link
G S100A4 S100 calcium binding protein A4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of S100A4 mRNA CTD PMID:28329830 NCBI chr 1:153,543,621...153,545,806
Ensembl chr 1:153,543,613...153,550,136 		JBrowse link
G SAT1 spermidine/spermine N1-acetyltransferase 1 multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of SAT1 mRNA CTD PMID:17690111 NCBI chr  X:23,783,173...23,786,210
Ensembl chr  X:23,783,173...23,786,210 		JBrowse link
G SBNO2 strawberry notch homolog 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SBNO2 mRNA CTD PMID:28329830 NCBI chr19:1,107,638...1,174,268
Ensembl chr19:1,107,637...1,174,268 		JBrowse link
G SC5D sterol-C5-desaturase decreases expression ISO fluoranthene results in decreased expression of SC5D mRNA CTD PMID:28329830 NCBI chr11:121,292,771...121,313,410
Ensembl chr11:121,292,681...121,313,410 		JBrowse link
G SCAMP5 secretory carrier membrane protein 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SCAMP5 mRNA CTD PMID:28329830 NCBI chr15:74,995,563...75,021,495
Ensembl chr15:74,957,219...75,021,495 		JBrowse link
G SCX scleraxis bHLH transcription factor decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of SCX mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of SCX mRNA		 CTD PMID:28329830 NCBI chr 8:144,266,453...144,268,481
Ensembl chr 8:144,266,453...144,268,481 		JBrowse link
G SDAD1 SDA1 domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SDAD1 mRNA CTD PMID:28329830 NCBI chr 4:75,949,915...75,990,945
Ensembl chr 4:75,940,950...75,990,962 		JBrowse link
G SDE2 SDE2 telomere maintenance homolog multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SDE2 mRNA CTD PMID:28329830 NCBI chr 1:225,982,702...225,999,343
Ensembl chr 1:225,982,702...225,999,343 		JBrowse link
G SEC16A SEC16 homolog A, endoplasmic reticulum export factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SEC16A mRNA CTD PMID:28329830 NCBI chr 9:136,440,105...136,484,740
Ensembl chr 9:136,440,096...136,483,759 		JBrowse link
G SEC23A SEC23 homolog A, COPII coat complex component multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SEC23A mRNA CTD PMID:28329830 NCBI chr14:39,031,919...39,103,235
Ensembl chr14:39,031,919...39,109,646 		JBrowse link
G SEC24A SEC24 homolog A, COPII coat complex component multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SEC24A mRNA CTD PMID:28329830 NCBI chr 5:134,648,382...134,727,909
Ensembl chr 5:134,648,785...134,727,909 		JBrowse link
G SEMA7A semaphorin 7A (JohnMiltonHagen blood group) decreases expression ISO fluoranthene results in decreased expression of SEMA7A mRNA CTD PMID:28329830 NCBI chr15:74,409,289...74,433,958
Ensembl chr15:74,409,289...74,433,958 		JBrowse link
G SENP8 SUMO peptidase family member, NEDD8 specific multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SENP8 mRNA CTD PMID:28329830 NCBI chr15:72,114,258...72,143,692
Ensembl chr15:72,114,258...72,143,692 		JBrowse link
G SEPHS2 selenophosphate synthetase 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SEPHS2 mRNA CTD PMID:28329830 NCBI chr16:30,443,631...30,445,874
Ensembl chr16:30,443,631...30,445,874 		JBrowse link
G SERPINA3 serpin family A member 3 multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of SERPINA3 mRNA CTD PMID:17690111 NCBI chr14:94,612,391...94,624,053
Ensembl chr14:94,612,384...94,624,055 		JBrowse link
G SERPINB2 serpin family B member 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SERPINB2 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of SERPINB2 mRNA] CTD PMID:28329830 NCBI chr18:63,887,705...63,903,888
Ensembl chr18:63,871,692...63,903,888 		JBrowse link
G SERPIND1 serpin family D member 1 multiple interactions ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of SERPIND1 mRNA CTD PMID:18711122 NCBI chr22:20,774,113...20,787,720
Ensembl chr22:20,774,113...20,787,720 		JBrowse link
G SESN1 sestrin 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SESN1 mRNA CTD PMID:28329830 NCBI chr 6:108,984,309...109,094,846
Ensembl chr 6:108,984,309...109,094,846 		JBrowse link
G SESN2 sestrin 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SESN2 mRNA CTD PMID:28329830 NCBI chr 1:28,259,518...28,282,491
Ensembl chr 1:28,259,518...28,282,491 		JBrowse link
G SGK1 serum/glucocorticoid regulated kinase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SGK1 mRNA CTD PMID:28329830 NCBI chr 6:134,169,256...134,318,112
Ensembl chr 6:134,169,248...134,318,112 		JBrowse link
G SH3BGRL3 SH3 domain binding glutamate rich protein like 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SH3BGRL3 mRNA CTD PMID:28329830 NCBI chr 1:26,280,086...26,281,522
Ensembl chr 1:26,280,086...26,281,522 		JBrowse link
G SIGMAR1 sigma non-opioid intracellular receptor 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SIGMAR1 mRNA CTD PMID:28329830 NCBI chr 9:34,634,722...34,637,787
Ensembl chr 9:34,634,722...34,637,844 		JBrowse link
G SKIL SKI like proto-oncogene multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SKIL mRNA CTD PMID:28329830 NCBI chr 3:170,357,715...170,396,849
Ensembl chr 3:170,357,342...170,396,835 		JBrowse link
G SLA Src like adaptor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLA mRNA CTD PMID:28329830 NCBI chr 8:133,036,728...133,102,602
Ensembl chr 8:133,036,728...133,102,912 		JBrowse link
G SLC12A2 solute carrier family 12 member 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC12A2 mRNA CTD PMID:28329830 NCBI chr 5:128,083,766...128,189,677
Ensembl chr 5:128,083,766...128,189,677 		JBrowse link
G SLC16A1 solute carrier family 16 member 1 multiple interactions ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of SLC16A1 mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of SLC16A1 mRNA CTD PMID:18711122 NCBI chr 1:112,911,847...112,956,196
Ensembl chr 1:112,911,847...112,957,593 		JBrowse link
G SLC16A2 solute carrier family 16 member 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC16A2 mRNA CTD PMID:28329830 NCBI chr  X:74,421,493...74,533,916
Ensembl chr  X:74,421,493...74,533,917 		JBrowse link
G SLC18B1 solute carrier family 18 member B1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC18B1 mRNA CTD PMID:28329830 NCBI chr 6:132,769,370...132,798,637
Ensembl chr 6:132,769,370...132,813,339 		JBrowse link
G SLC1A4 solute carrier family 1 member 4 increases expression
multiple interactions		 ISO fluoranthene results in increased expression of SLC1A4 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC1A4 mRNA		 CTD PMID:28329830 NCBI chr 2:64,988,479...65,023,865
Ensembl chr 2:64,988,477...65,023,865 		JBrowse link
G SLC20A1 solute carrier family 20 member 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC20A1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC20A1 mRNA] CTD PMID:28329830 NCBI chr 2:112,645,939...112,663,825
Ensembl chr 2:112,645,939...112,663,825 		JBrowse link
G SLC22A23 solute carrier family 22 member 23 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC22A23 mRNA CTD PMID:28329830 NCBI chr 6:3,268,973...3,457,050
Ensembl chr 6:3,268,962...3,457,050 		JBrowse link
G SLC25A13 solute carrier family 25 member 13 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC25A13 mRNA CTD PMID:28329830 NCBI chr 7:96,120,220...96,322,098
Ensembl chr 7:96,120,220...96,322,147 		JBrowse link
G SLC25A23 solute carrier family 25 member 23 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC25A23 mRNA CTD PMID:28329830 NCBI chr19:6,436,081...6,459,792
Ensembl chr19:6,436,079...6,465,203 		JBrowse link
G SLC25A25 solute carrier family 25 member 25 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC25A25 mRNA CTD PMID:28329830 NCBI chr 9:128,068,232...128,109,245
Ensembl chr 9:128,068,201...128,109,245 		JBrowse link
G SLC25A30 solute carrier family 25 member 30 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC25A30 mRNA CTD PMID:28329830 NCBI chr13:45,393,316...45,434,016
Ensembl chr13:45,393,316...45,418,455 		JBrowse link
G SLC25A37 solute carrier family 25 member 37 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC25A37 mRNA CTD PMID:28329830 NCBI chr 8:23,528,956...23,575,463
Ensembl chr 8:23,528,956...23,575,463 		JBrowse link
G SLC29A3 solute carrier family 29 member 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC29A3 mRNA CTD PMID:28329830 NCBI chr10:71,319,259...71,381,423
Ensembl chr10:71,319,259...71,381,423 		JBrowse link
G SLC30A4 solute carrier family 30 member 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC30A4 mRNA CTD PMID:28329830 NCBI chr15:45,479,606...45,522,755
Ensembl chr15:45,479,606...45,522,755 		JBrowse link
G SLC31A2 solute carrier family 31 member 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC31A2 mRNA CTD PMID:28329830 NCBI chr 9:113,151,007...113,164,140
Ensembl chr 9:113,150,976...113,164,140 		JBrowse link
G SLC35D2 solute carrier family 35 member D2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC35D2 mRNA CTD PMID:28329830 NCBI chr 9:96,313,444...96,383,711
Ensembl chr 9:96,313,444...96,383,711 		JBrowse link
G SLC35G1 solute carrier family 35 member G1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC35G1 mRNA CTD PMID:28329830 NCBI chr10:93,893,978...93,909,830
Ensembl chr10:93,893,973...93,956,062 		JBrowse link
G SLC38A2 solute carrier family 38 member 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC38A2 mRNA CTD PMID:28329830 NCBI chr12:46,358,188...46,372,773
Ensembl chr12:46,358,188...46,372,773 		JBrowse link
G SLC38A6 solute carrier family 38 member 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC38A6 mRNA CTD PMID:28329830 NCBI chr14:60,981,245...61,083,733
Ensembl chr14:60,981,114...61,114,316 		JBrowse link
G SLC3A2 solute carrier family 3 member 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC3A2 mRNA CTD PMID:28329830 NCBI chr11:62,856,109...62,888,860
Ensembl chr11:62,856,004...62,888,880 		JBrowse link
G SLC7A1 solute carrier family 7 member 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A1 mRNA] CTD PMID:28329830 NCBI chr13:29,509,414...29,595,688
Ensembl chr13:29,509,414...29,595,688 		JBrowse link
G SLC7A11 solute carrier family 7 member 11 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A11 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A11 mRNA] CTD PMID:28329830 NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349 		JBrowse link
G SMAD3 SMAD family member 3 multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of SMAD3 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of SMAD3 mRNA		 CTD PMID:18711122 PMID:28329830 NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173 		JBrowse link
G SMAD6 SMAD family member 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SMAD6 mRNA CTD PMID:28329830 NCBI chr15:66,702,236...66,782,849
Ensembl chr15:66,702,236...66,782,849 		JBrowse link
G SMIM11 small integral membrane protein 11 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SMIM11 mRNA CTD PMID:28329830 NCBI chr21:34,375,507...34,389,151
Ensembl chr21:34,375,480...34,416,961 		JBrowse link
G SMIM3 small integral membrane protein 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SMIM3 mRNA CTD PMID:28329830 NCBI chr 5:150,778,757...150,796,734
Ensembl chr 5:150,778,757...150,796,734 		JBrowse link
G SMTNL2 smoothelin like 2 multiple interactions
decreases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SMTNL2 mRNA
fluoranthene results in decreased expression of SMTNL2 mRNA		 CTD PMID:28329830 NCBI chr17:4,584,007...4,608,319
Ensembl chr17:4,583,999...4,608,319 		JBrowse link
G SNAI2 snail family transcriptional repressor 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SNAI2 mRNA CTD PMID:28329830 NCBI chr 8:48,917,598...48,921,429
Ensembl chr 8:48,917,598...48,921,740 		JBrowse link
G SNAPIN SNAP associated protein multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SNAPIN mRNA CTD PMID:28329830 NCBI chr 1:153,658,654...153,661,852
Ensembl chr 1:153,658,703...153,661,852 		JBrowse link
G SNHG12 small nucleolar RNA host gene 12 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SNHG12 mRNA CTD PMID:28329830 NCBI chr 1:28,578,538...28,582,983
Ensembl chr 1:28,578,538...28,583,132 		JBrowse link
G SNHG5 small nucleolar RNA host gene 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SNHG5 mRNA CTD PMID:28329830 NCBI chr 6:85,677,007...85,678,733
Ensembl chr 6:85,650,491...85,678,932 		JBrowse link
G SNHG6 small nucleolar RNA host gene 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SNHG6 mRNA CTD PMID:28329830 NCBI chr 8:66,921,690...66,925,541
Ensembl chr 8:66,920,561...66,926,398 		JBrowse link
G SNORA23 small nucleolar RNA, H/ACA box 23 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SNORA23 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of SNORA23 mRNA] CTD PMID:28329830 NCBI chr11:9,428,766...9,428,954
Ensembl chr11:9,428,773...9,428,954 		JBrowse link
G SNORA62 small nucleolar RNA, H/ACA box 62 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SNORA62 mRNA CTD PMID:28329830 NCBI chr 3:39,411,054...39,411,207
Ensembl chr 3:39,411,054...39,411,206 		JBrowse link
G SNORA75 small nucleolar RNA, H/ACA box 75 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SNORA75 mRNA CTD PMID:28329830 NCBI chr 2:231,455,800...231,455,936
Ensembl chr 2:231,455,800...231,455,936 		JBrowse link
G SNORD104 small nucleolar RNA, C/D box 104 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SNORD104 mRNA CTD PMID:28329830 NCBI chr17:64,146,078...64,146,157
Ensembl chr17:64,146,083...64,146,152 		JBrowse link
G SNX7 sorting nexin 7 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SNX7 mRNA CTD PMID:28329830 NCBI chr 1:98,661,319...98,760,500
Ensembl chr 1:98,661,701...98,760,500 		JBrowse link
G SOCS3 suppressor of cytokine signaling 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SOCS3 mRNA CTD PMID:28329830 NCBI chr17:78,356,778...78,360,925
Ensembl chr17:78,356,778...78,360,077 		JBrowse link
G SORBS3 sorbin and SH3 domain containing 3 decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of SORBS3 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of SORBS3 mRNA		 CTD PMID:28329830 NCBI chr 8:22,544,973...22,575,788
Ensembl chr 8:22,544,986...22,575,788 		JBrowse link
G SOX4 SRY-box transcription factor 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SOX4 mRNA CTD PMID:28329830 NCBI chr 6:21,593,751...21,598,619
Ensembl chr 6:21,593,751...21,598,619 		JBrowse link
G SP3 Sp3 transcription factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SP3 mRNA CTD PMID:28329830 NCBI chr 2:173,900,775...173,965,702
Ensembl chr 2:173,880,850...173,965,373 		JBrowse link
G SPP1 secreted phosphoprotein 1 multiple interactions EXP
ISO		 [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of SPP1 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of SPP1 mRNA		 CTD PMID:17690111 PMID:28329830 NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532 		JBrowse link
G SPRED1 sprouty related EVH1 domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SPRED1 mRNA CTD PMID:28329830 NCBI chr15:38,252,836...38,357,249
Ensembl chr15:38,252,836...38,357,249 		JBrowse link
G SPRY2 sprouty RTK signaling antagonist 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SPRY2 mRNA CTD PMID:28329830 NCBI chr13:80,335,976...80,341,126
Ensembl chr13:80,335,976...80,341,126 		JBrowse link
G SPRY4 sprouty RTK signaling antagonist 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SPRY4 mRNA CTD PMID:28329830 NCBI chr 5:142,310,430...142,325,021
Ensembl chr 5:142,310,427...142,326,455 		JBrowse link
G SPTBN2 spectrin beta, non-erythrocytic 2 multiple interactions ISO [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of SPTBN2 mRNA CTD PMID:18711122 NCBI chr11:66,682,497...66,744,682
Ensembl chr11:66,682,496...66,744,670 		JBrowse link
G SPTY2D1 SPT2 chromatin protein domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SPTY2D1 mRNA CTD PMID:28329830 NCBI chr11:18,606,403...18,634,342
Ensembl chr11:18,606,403...18,634,791 		JBrowse link
G SQLE squalene epoxidase multiple interactions
decreases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SQLE mRNA
fluoranthene results in decreased expression of SQLE mRNA		 CTD PMID:28329830 NCBI chr 8:124,998,505...125,022,283
Ensembl chr 8:124,998,497...125,022,283 		JBrowse link
G SRGAP3 SLIT-ROBO Rho GTPase activating protein 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SRGAP3 mRNA CTD PMID:28329830 NCBI chr 3:8,980,591...9,363,027
Ensembl chr 3:8,980,591...9,363,053 		JBrowse link
G SRI sorcin multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SRI mRNA CTD PMID:28329830 NCBI chr 7:88,205,115...88,226,976
Ensembl chr 7:88,205,115...88,226,993 		JBrowse link
G STAM signal transducing adaptor molecule multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of STAM mRNA CTD PMID:28329830 NCBI chr10:17,644,151...17,716,824
Ensembl chr10:17,644,151...17,716,824 		JBrowse link
G STAMBPL1 STAM binding protein like 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of STAMBPL1 mRNA CTD PMID:28329830 NCBI chr10:88,880,245...88,923,487
Ensembl chr10:88,879,734...88,975,153 		JBrowse link
G STARD10 StAR related lipid transfer domain containing 10 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of STARD10 mRNA CTD PMID:28329830 NCBI chr11:72,754,729...72,794,047
Ensembl chr11:72,754,729...72,794,047 		JBrowse link
G STARD4 StAR related lipid transfer domain containing 4 decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of STARD4 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of STARD4 mRNA		 CTD PMID:28329830 NCBI chr 5:111,496,033...111,512,535
Ensembl chr 5:111,496,033...111,512,590 		JBrowse link
G STC1 stanniocalcin 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of STC1 mRNA CTD PMID:28329830 NCBI chr 8:23,841,929...23,854,806
Ensembl chr 8:23,841,929...23,854,806 		JBrowse link
G STK40 serine/threonine kinase 40 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of STK40 mRNA CTD PMID:28329830 NCBI chr 1:36,339,628...36,385,924
Ensembl chr 1:36,339,624...36,385,924 		JBrowse link
G STX3 syntaxin 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of STX3 mRNA CTD PMID:28329830 NCBI chr11:59,754,188...59,805,878
Ensembl chr11:59,713,456...59,805,882 		JBrowse link
G SUCO SUN domain containing ossification factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SUCO mRNA CTD PMID:28329830 NCBI chr 1:172,532,349...172,611,833
Ensembl chr 1:172,532,349...172,611,833 		JBrowse link
G SUOX sulfite oxidase multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SUOX mRNA CTD PMID:28329830 NCBI chr12:55,997,276...56,005,525
Ensembl chr12:55,997,180...56,006,641 		JBrowse link
G SYDE1 synapse defective Rho GTPase homolog 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SYDE1 mRNA CTD PMID:28329830 NCBI chr19:15,107,401...15,114,974
Ensembl chr19:15,107,401...15,114,985 		JBrowse link
G SYNJ2 synaptojanin 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of SYNJ2 mRNA CTD PMID:28329830 NCBI chr 6:157,981,296...158,099,176
Ensembl chr 6:157,981,863...158,099,176 		JBrowse link
G TAF1A TATA-box binding protein associated factor, RNA polymerase I subunit A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TAF1A mRNA CTD PMID:28329830 NCBI chr 1:222,554,105...222,589,933
Ensembl chr 1:222,557,902...222,589,933 		JBrowse link
G TAF1D TATA-box binding protein associated factor, RNA polymerase I subunit D multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TAF1D mRNA CTD PMID:28329830 NCBI chr11:93,730,194...93,741,495
Ensembl chr11:93,729,948...93,784,391 		JBrowse link
G TAF4B TATA-box binding protein associated factor 4b multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TAF4B mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of TAF4B mRNA] CTD PMID:28329830 NCBI chr18:26,226,445...26,391,685
Ensembl chr18:26,226,445...26,391,685 		JBrowse link
G TAF5 TATA-box binding protein associated factor 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TAF5 mRNA CTD PMID:28329830 NCBI chr10:103,367,976...103,389,065
Ensembl chr10:103,367,966...103,389,065 		JBrowse link
G TANC2 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TANC2 mRNA CTD PMID:28329830 NCBI chr17:62,966,235...63,427,703
Ensembl chr17:62,966,235...63,427,703 		JBrowse link
G TANK TRAF family member associated NFKB activator multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TANK mRNA CTD PMID:28329830 NCBI chr 2:161,136,963...161,236,230
Ensembl chr 2:161,136,908...161,236,230 		JBrowse link
G TATDN2 TatD DNase domain containing 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TATDN2 mRNA CTD PMID:28329830 NCBI chr 3:10,248,459...10,281,218
Ensembl chr 3:10,248,023...10,281,218 		JBrowse link
G TBC1D15 TBC1 domain family member 15 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TBC1D15 mRNA CTD PMID:28329830 NCBI chr12:71,839,759...71,924,313
Ensembl chr12:71,839,707...71,927,248 		JBrowse link
G TBC1D23 TBC1 domain family member 23 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TBC1D23 mRNA CTD PMID:28329830 NCBI chr 3:100,260,992...100,325,238
Ensembl chr 3:100,260,992...100,325,251 		JBrowse link
G TBC1D31 TBC1 domain family member 31 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TBC1D31 mRNA CTD PMID:28329830 NCBI chr 8:123,072,707...123,165,173
Ensembl chr 8:123,041,968...123,152,153 		JBrowse link
G TBCCD1 TBCC domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TBCCD1 mRNA CTD PMID:28329830 NCBI chr 3:186,546,067...186,570,543
Ensembl chr 3:186,546,067...186,570,543 		JBrowse link
G TCP11L2 t-complex 11 like 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TCP11L2 mRNA CTD PMID:28329830 NCBI chr12:106,297,935...106,347,003
Ensembl chr12:106,301,929...106,347,003 		JBrowse link
G TEF TEF transcription factor, PAR bZIP family member multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TEF mRNA CTD PMID:28329830 NCBI chr22:41,367,455...41,399,326
Ensembl chr22:41,367,333...41,399,326 		JBrowse link
G TEX261 testis expressed 261 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TEX261 mRNA CTD PMID:28329830 NCBI chr 2:70,985,942...70,994,873
Ensembl chr 2:70,968,325...70,994,873 		JBrowse link
G TGFB1 transforming growth factor beta 1 multiple interactions
increases expression		 EXP TNF protein inhibits the reaction [fluoranthene results in increased expression of TGFB1 mRNA] CTD PMID:18434080 NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922 		JBrowse link
G TGIF1 TGFB induced factor homeobox 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TGIF1 mRNA CTD PMID:28329830 NCBI chr18:3,412,009...3,459,978
Ensembl chr18:3,411,608...3,459,978 		JBrowse link
G TGOLN2 trans-golgi network protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TGOLN1 mRNA CTD PMID:28329830 NCBI chr 2:85,318,027...85,327,989
Ensembl chr 2:85,318,027...85,328,251 		JBrowse link
G THBD thrombomodulin decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of THBD mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of THBD mRNA		 CTD PMID:28329830 NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672 		JBrowse link
G THEM4 thioesterase superfamily member 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of THEM4 mRNA CTD PMID:28329830 NCBI chr 1:151,870,866...151,909,511
Ensembl chr 1:151,870,866...151,909,637 		JBrowse link
G THEM6 thioesterase superfamily member 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of THEM6 mRNA CTD PMID:28329830 NCBI chr 8:142,727,223...142,736,927
Ensembl chr 8:142,727,223...142,736,927 		JBrowse link
G TIPARP TCDD inducible poly(ADP-ribose) polymerase increases expression
multiple interactions		 ISO fluoranthene results in increased expression of TIPARP mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of TIPARP mRNA
TNF protein inhibits the reaction [fluoranthene results in increased expression of TIPARP mRNA]		 CTD PMID:25268939 PMID:28329830 NCBI chr 3:156,674,590...156,706,770
Ensembl chr 3:156,673,235...156,706,770 		JBrowse link
G TLCD1 TLC domain containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TLCD1 mRNA CTD PMID:28329830 NCBI chr17:28,724,348...28,727,937
Ensembl chr17:28,724,348...28,727,935 		JBrowse link
G TLCD3A TLC domain containing 3A decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of TLCD3A mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of TLCD3A mRNA		 CTD PMID:28329830 NCBI chr17:732,596...742,968
Ensembl chr17:732,412...742,968 		JBrowse link
G TLE5 TLE family member 5, transcriptional modulator multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TLE5 mRNA CTD PMID:28329830 NCBI chr19:3,052,910...3,062,966
Ensembl chr19:3,052,910...3,063,107 		JBrowse link
G TLNRD1 talin rod domain containing 1 decreases expression ISO fluoranthene results in decreased expression of TLNRD1 mRNA CTD PMID:28329830 NCBI chr15:81,000,923...81,005,788
Ensembl chr15:81,000,923...81,005,788 		JBrowse link
G TMEM11 transmembrane protein 11 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TMEM11 mRNA CTD PMID:28329830 NCBI chr17:21,197,954...21,214,161
Ensembl chr17:21,197,954...21,214,176 		JBrowse link
G TMEM140 transmembrane protein 140 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TMEM140 mRNA CTD PMID:28329830 NCBI chr 7:135,148,072...135,166,215
Ensembl chr 7:135,148,072...135,166,215 		JBrowse link
G TMEM164 transmembrane protein 164 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TMEM164 mRNA CTD PMID:28329830 NCBI chr  X:110,002,369...110,184,251
Ensembl chr  X:110,002,631...110,182,734 		JBrowse link
G TMEM170A transmembrane protein 170A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TMEM170 mRNA CTD PMID:28329830 NCBI chr16:75,443,054...75,464,737
Ensembl chr16:75,443,054...75,465,497 		JBrowse link
G TMEM175 transmembrane protein 175 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TMEM175 mRNA CTD PMID:28329830 NCBI chr 4:932,460...958,656
Ensembl chr 4:932,387...958,656 		JBrowse link
G TMEM19 transmembrane protein 19 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TMEM19 mRNA CTD PMID:28329830 NCBI chr12:71,686,082...71,705,047
Ensembl chr12:71,686,082...71,705,047 		JBrowse link
G TMEM254 transmembrane protein 254 decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of TMEM254 mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of TMEM254 mRNA		 CTD PMID:28329830 NCBI chr10:80,078,665...80,092,551
Ensembl chr10:80,078,646...80,092,557 		JBrowse link
G TMEM39A transmembrane protein 39A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TMEM39A mRNA CTD PMID:28329830 NCBI chr 3:119,428,949...119,463,615
Ensembl chr 3:119,428,949...119,468,830 		JBrowse link
G TMEM86A transmembrane protein 86A multiple interactions
decreases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TMEM86A mRNA
fluoranthene results in decreased expression of TMEM86A mRNA		 CTD PMID:28329830 NCBI chr11:18,698,779...18,704,785
Ensembl chr11:18,693,122...18,704,785 		JBrowse link
G TMEM97 transmembrane protein 97 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TMEM97 mRNA CTD PMID:28329830 NCBI chr17:28,319,200...28,328,685
Ensembl chr17:28,319,200...28,328,685 		JBrowse link
G TNF tumor necrosis factor multiple interactions
increases response to substance		 EXP
ISO		 TNF protein inhibits the reaction [fluoranthene results in increased expression of IL4 mRNA]; TNF protein inhibits the reaction [fluoranthene results in increased expression of TGFB1 mRNA]; TNF protein promotes the reaction [fluoranthene results in increased expression of CXCL8 mRNA]; TNF protein promotes the reaction [fluoranthene results in increased expression of IL6 mRNA]; TNF protein promotes the reaction [fluoranthene results in increased secretion of CXCL8 protein]
TNF protein inhibits the reaction [fluoranthene results in increased expression of AHRR mRNA]; TNF protein inhibits the reaction [fluoranthene results in increased expression of CYP1A1 mRNA]; TNF protein inhibits the reaction [fluoranthene results in increased expression of TIPARP mRNA]; TNF protein promotes the reaction [fluoranthene results in increased expression of CYP1B1 mRNA]
fluoranthene results in increased susceptibility to TNF protein		 CTD PMID:18434080 PMID:25268939 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
G TNFAIP3 TNF alpha induced protein 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TNFAIP3 mRNA CTD PMID:28329830 NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314 		JBrowse link
G TNFAIP6 TNF alpha induced protein 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TNFAIP6 mRNA CTD PMID:28329830 NCBI chr 2:151,357,592...151,381,340
Ensembl chr 2:151,357,592...151,380,046 		JBrowse link
G TNFRSF12A TNF receptor superfamily member 12A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TNFRSF12A mRNA CTD PMID:28329830 NCBI chr16:3,020,368...3,022,383
Ensembl chr16:3,018,445...3,022,383 		JBrowse link
G TNFRSF1B TNF receptor superfamily member 1B multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TNFRSF1B mRNA CTD PMID:28329830 NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228 		JBrowse link
G TNFRSF21 TNF receptor superfamily member 21 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TNFRSF21 mRNA CTD PMID:28329830 NCBI chr 6:47,231,532...47,309,905
Ensembl chr 6:47,231,532...47,309,905 		JBrowse link
G TNS4 tensin 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TNS4 mRNA CTD PMID:28329830 NCBI chr17:40,475,834...40,501,623
Ensembl chr17:40,475,828...40,501,623 		JBrowse link
G TOB1 transducer of ERBB2, 1 decreases expression ISO fluoranthene results in decreased expression of TOB1 mRNA CTD PMID:28329830 NCBI chr17:50,862,223...50,867,978
Ensembl chr17:50,862,223...50,867,978 		JBrowse link
G TOP1 DNA topoisomerase I multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TOP1 mRNA CTD PMID:28329830 NCBI chr20:41,028,822...41,124,487
Ensembl chr20:41,028,822...41,124,487 		JBrowse link
G TP53 tumor protein p53 multiple interactions
increases expression		 EXP
ISO		 fluoranthene promotes the reaction [Benzo(a)pyrene results in increased expression of TP53 protein]
fluoranthene results in increased expression of TRP53 protein
fluoranthene promotes the reaction [Benzo(a)pyrene results in increased expression of TRP53 mRNA]; fluoranthene promotes the reaction [Benzo(a)pyrene results in increased expression of TRP53 protein]; fluoranthene promotes the reaction [Benzo(a)pyrene results in increased phosphorylation of TRP53 protein]; TRP53 results in increased susceptibility to [Benzo(a)pyrene co-treated with fluoranthene]		 CTD PMID:22120587 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546 		JBrowse link
G TP53BP2 tumor protein p53 binding protein 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TRP53BP2 mRNA CTD PMID:28329830 NCBI chr 1:223,779,893...223,845,947
Ensembl chr 1:223,779,893...223,845,954 		JBrowse link
G TRAF5 TNF receptor associated factor 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TRAF5 mRNA CTD PMID:28329830 NCBI chr 1:211,326,635...211,374,946
Ensembl chr 1:211,326,615...211,374,946 		JBrowse link
G TRAPPC1 trafficking protein particle complex subunit 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TRAPPC1 mRNA CTD PMID:28329830 NCBI chr17:7,930,345...7,931,999
Ensembl chr17:7,930,345...7,932,123 		JBrowse link
G TRAPPC6A trafficking protein particle complex subunit 6A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TRAPPC6A mRNA CTD PMID:28329830 NCBI chr19:45,162,933...45,178,237
Ensembl chr19:45,162,928...45,178,237 		JBrowse link
G TRIB1 tribbles pseudokinase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TRIB1 mRNA CTD PMID:28329830 NCBI chr 8:125,430,358...125,438,403
Ensembl chr 8:125,430,358...125,438,403 		JBrowse link
G TRIB3 tribbles pseudokinase 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TRIB3 mRNA CTD PMID:28329830 NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559 		JBrowse link
G TRIM33 tripartite motif containing 33 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TRIM33 mRNA CTD PMID:28329830 NCBI chr 1:114,392,790...114,511,203
Ensembl chr 1:114,392,790...114,511,203 		JBrowse link
G TRMT10C tRNA methyltransferase 10C, mitochondrial RNase P subunit multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TRMT10C mRNA CTD PMID:28329830 NCBI chr 3:101,561,868...101,566,446
Ensembl chr 3:101,561,868...101,566,446 		JBrowse link
G TRMT13 tRNA methyltransferase 13 homolog multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TRMT13 mRNA CTD PMID:28329830 NCBI chr 1:100,133,163...100,150,496
Ensembl chr 1:100,133,150...100,150,496 		JBrowse link
G TRMT61A tRNA methyltransferase 61A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TRMT61A mRNA CTD PMID:28329830 NCBI chr14:103,529,196...103,537,073
Ensembl chr14:103,529,196...103,537,073 		JBrowse link
G TRUB1 TruB pseudouridine synthase family member 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TRUB1 mRNA CTD PMID:28329830 NCBI chr10:114,938,195...114,977,676
Ensembl chr10:114,938,195...114,977,676 		JBrowse link
G TSC22D3 TSC22 domain family member 3 multiple interactions ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of TSC22D3 mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of TSC22D3 mRNA		 CTD PMID:18711122 PMID:28329830 NCBI chr  X:107,713,221...107,775,988
Ensembl chr  X:107,713,221...107,777,342 		JBrowse link
G TSPAN15 tetraspanin 15 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TSPAN15 mRNA CTD PMID:28329830 NCBI chr10:69,451,465...69,549,508
Ensembl chr10:69,451,465...69,507,666 		JBrowse link
G TSR1 TSR1 ribosome maturation factor multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TSR1 mRNA CTD PMID:28329830 NCBI chr17:2,322,396...2,336,457
Ensembl chr17:2,322,396...2,336,657 		JBrowse link
G TSTD3 thiosulfate sulfurtransferase like domain containing 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TSTD3 mRNA CTD PMID:28329830 NCBI chr 6:99,424,906...99,586,256
Ensembl chr 6:99,520,976...99,589,899 		JBrowse link
G TTLL1 TTL family tubulin polyglutamylase complex subunit L1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TTLL1 mRNA CTD PMID:28329830 NCBI chr22:43,039,516...43,089,391
Ensembl chr22:43,039,516...43,089,419 		JBrowse link
G TTYH3 tweety family member 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TTYH3 mRNA CTD PMID:28329830 NCBI chr 7:2,631,986...2,664,802
Ensembl chr 7:2,631,961...2,664,802 		JBrowse link
G TUBA1A tubulin alpha 1a multiple interactions
decreases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TUBA1A mRNA
fluoranthene results in decreased expression of TUBA1A mRNA		 CTD PMID:28329830 NCBI chr12:49,184,795...49,189,080
Ensembl chr12:49,184,686...49,189,324 		JBrowse link
G TUBB tubulin beta class I multiple interactions ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of TUBB5 mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of TUBB5 mRNA CTD PMID:18711122 NCBI chr 6:30,720,352...30,725,422
Ensembl chr 6:30,717,435...30,725,538 		JBrowse link
G TVP23A trans-golgi network vesicle protein 23 homolog A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TVP23A mRNA CTD PMID:28329830 NCBI chr16:10,757,318...10,818,794
Ensembl chr16:10,760,919...10,818,794 		JBrowse link
G TWSG1 twisted gastrulation BMP signaling modulator 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of TWSG1 mRNA CTD PMID:28329830 NCBI chr18:9,334,773...9,402,420
Ensembl chr18:9,334,767...9,402,420 		JBrowse link
G TXNIP thioredoxin interacting protein decreases expression
multiple interactions		 ISO fluoranthene results in decreased expression of TXNIP mRNA
[1-methylanthracene co-treated with fluoranthene] results in decreased expression of TXNIP mRNA		 CTD PMID:28329830 NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579 		JBrowse link
G TXNRD1 thioredoxin reductase 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of TXNRD1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of TXNRD1 mRNA] CTD PMID:28329830 NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307 		JBrowse link
G TYROBP transmembrane immune signaling adaptor TYROBP multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of TYROBP mRNA CTD PMID:17690111 NCBI chr19:35,904,403...35,908,295
Ensembl chr19:35,904,401...35,908,295 		JBrowse link
G UBC ubiquitin C multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of UBC mRNA CTD PMID:28329830 NCBI chr12:124,911,646...124,914,650
Ensembl chr12:124,911,604...124,917,368 		JBrowse link
G UBN1 ubinuclein 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of UBN1 mRNA CTD PMID:28329830 NCBI chr16:4,847,481...4,882,401
Ensembl chr16:4,846,665...4,882,401 		JBrowse link
G UGCG UDP-glucose ceramide glucosyltransferase multiple interactions ISO [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of UGCG mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of UGCG mRNA		 CTD PMID:18711122 PMID:28329830 NCBI chr 9:111,896,814...111,935,369
Ensembl chr 9:111,896,814...111,935,369 		JBrowse link
G USP36 ubiquitin specific peptidase 36 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of USP36 mRNA CTD PMID:28329830 NCBI chr17:78,787,381...78,841,439
Ensembl chr17:78,787,381...78,841,441 		JBrowse link
G USP53 ubiquitin specific peptidase 53 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of USP53 mRNA CTD PMID:28329830 NCBI chr 4:119,212,601...119,295,518
Ensembl chr 4:119,212,587...119,295,518 		JBrowse link
G USP54 ubiquitin specific peptidase 54 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of USP54 mRNA CTD PMID:28329830 NCBI chr10:73,497,538...73,625,981
Ensembl chr10:73,497,538...73,626,117 		JBrowse link
G VCAM1 vascular cell adhesion molecule 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of VCAM1 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of VCAM1 mRNA] CTD PMID:28329830 NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045 		JBrowse link
G VEGFA vascular endothelial growth factor A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of VEGFA mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of VEGFA mRNA] CTD PMID:28329830 NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487 		JBrowse link
G VMP1 vacuole membrane protein 1 increases expression EXP fluoranthene results in increased expression of VMP1 mRNA CTD PMID:16269432 NCBI chr17:59,707,654...59,842,255
Ensembl chr17:59,707,192...59,842,255 		JBrowse link
G VPS37B VPS37B subunit of ESCRT-I multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of VPS37B mRNA CTD PMID:28329830 NCBI chr12:122,865,330...122,896,124
Ensembl chr12:122,865,330...122,896,127 		JBrowse link
G WBP1 WW domain binding protein 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of WBP1 mRNA CTD PMID:28329830 NCBI chr 2:74,458,438...74,460,881
Ensembl chr 2:74,458,400...74,460,891 		JBrowse link
G WDR43 WD repeat domain 43 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of WDR43 mRNA CTD PMID:28329830 NCBI chr 2:28,894,667...28,948,219
Ensembl chr 2:28,894,667...28,948,219 		JBrowse link
G WDR83OS WD repeat domain 83 opposite strand multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of WDR83OS mRNA CTD PMID:28329830 NCBI chr19:12,668,073...12,669,415
Ensembl chr19:12,668,073...12,669,415 		JBrowse link
G WNT5A Wnt family member 5A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of WNT5A mRNA CTD PMID:28329830 NCBI chr 3:55,465,715...55,505,263
Ensembl chr 3:55,465,715...55,490,539 		JBrowse link
G WNT9A Wnt family member 9A multiple interactions
decreases expression		 ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of WNT9A mRNA
fluoranthene results in decreased expression of WNT9A mRNA		 CTD PMID:28329830 NCBI chr 1:227,918,656...227,947,932
Ensembl chr 1:227,918,656...227,947,932 		JBrowse link
G XDH xanthine dehydrogenase increases expression
multiple interactions		 ISO fluoranthene results in increased expression of XDH mRNA
[1-methylanthracene co-treated with fluoranthene] results in increased expression of XDH mRNA		 CTD PMID:28329830 NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742 		JBrowse link
G XRCC1 X-ray repair cross complementing 1 multiple interactions EXP [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of XRCC1 mRNA CTD PMID:17690111 NCBI chr19:43,543,311...43,575,527
Ensembl chr19:43,543,311...43,580,473 		JBrowse link
G YPEL2 yippee like 2 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of YPEL2 mRNA CTD PMID:28329830 NCBI chr17:59,331,655...59,401,729
Ensembl chr17:59,331,655...59,401,729 		JBrowse link
G ZBED5 zinc finger BED-type containing 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZBED5 mRNA CTD PMID:28329830 NCBI chr11:10,852,706...10,858,053
Ensembl chr11:10,812,074...10,858,796 		JBrowse link
G ZBTB10 zinc finger and BTB domain containing 10 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZBTB10 mRNA CTD PMID:28329830 NCBI chr 8:80,485,593...80,526,265
Ensembl chr 8:80,485,619...80,526,265 		JBrowse link
G ZBTB11 zinc finger and BTB domain containing 11 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZBTB11 mRNA CTD PMID:28329830 NCBI chr 3:101,648,889...101,677,132
Ensembl chr 3:101,648,889...101,677,135 		JBrowse link
G ZBTB14 zinc finger and BTB domain containing 14 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ZBTB14 mRNA CTD PMID:28329830 NCBI chr18:5,289,022...5,297,053
Ensembl chr18:5,289,019...5,297,053 		JBrowse link
G ZBTB3 zinc finger and BTB domain containing 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ZBTB3 mRNA CTD PMID:28329830 NCBI chr11:62,750,963...62,754,160
Ensembl chr11:62,748,319...62,754,184 		JBrowse link
G ZC3H12A zinc finger CCCH-type containing 12A multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZC3H12A mRNA CTD PMID:28329830 NCBI chr 1:37,474,580...37,484,377
Ensembl chr 1:37,474,580...37,484,377 		JBrowse link
G ZC3H3 zinc finger CCCH-type containing 3 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZC3H3 mRNA CTD PMID:28329830 NCBI chr 8:143,437,659...143,541,447
Ensembl chr 8:143,437,659...143,541,447 		JBrowse link
G ZC3HAV1L zinc finger CCCH-type containing, antiviral 1 like multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ZC3HAV1L mRNA CTD PMID:28329830 NCBI chr 7:139,021,498...139,036,042
Ensembl chr 7:139,025,706...139,036,042 		JBrowse link
G ZC4H2 zinc finger C4H2-type containing multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ZC4H2 mRNA CTD PMID:28329830 NCBI chr  X:64,915,807...65,034,741
Ensembl chr  X:64,915,802...65,034,713 		JBrowse link
G ZCCHC17 zinc finger CCHC-type containing 17 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ZCCHC17 mRNA CTD PMID:28329830 NCBI chr 1:31,297,032...31,364,936
Ensembl chr 1:31,296,982...31,364,953 		JBrowse link
G ZCCHC7 zinc finger CCHC-type containing 7 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZCCHC7 mRNA CTD PMID:28329830 NCBI chr 9:37,120,167...37,358,149
Ensembl chr 9:37,120,574...37,358,149 		JBrowse link
G ZFAND5 zinc finger AN1-type containing 5 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZFAND5 mRNA CTD PMID:28329830 NCBI chr 9:72,351,413...72,365,208
Ensembl chr 9:72,351,413...72,365,235 		JBrowse link
G ZFP36 ZFP36 ring finger protein multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZFP36 mRNA CTD PMID:28329830 NCBI chr19:39,406,847...39,409,407
Ensembl chr19:39,406,847...39,409,407 		JBrowse link
G ZFP36L1 ZFP36 ring finger protein like 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZFP36L1 mRNA CTD PMID:28329830 NCBI chr14:68,787,655...68,796,243
Ensembl chr14:68,787,660...68,796,253 		JBrowse link
G ZNF248 zinc finger protein 248 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ZFP248 mRNA CTD PMID:28329830 NCBI chr10:37,758,538...37,858,103
Ensembl chr10:37,776,526...37,858,106 		JBrowse link
G ZNF25 zinc finger protein 25 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZFP9 mRNA CTD PMID:28329830 NCBI chr10:37,949,573...37,976,647
Ensembl chr10:37,949,573...37,976,647 		JBrowse link
G ZNF322 zinc finger protein 322 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ZFP322A mRNA CTD PMID:28329830 NCBI chr 6:26,634,383...26,659,746
Ensembl chr 6:26,634,383...26,659,752 		JBrowse link
G ZNF324 zinc finger protein 324 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ZFP324 mRNA CTD PMID:28329830 NCBI chr19:58,467,080...58,475,436
Ensembl chr19:58,467,056...58,475,436 		JBrowse link
G ZNF330 zinc finger protein 330 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZFP330 mRNA CTD PMID:28329830 NCBI chr 4:141,220,535...141,234,697
Ensembl chr 4:141,220,887...141,234,697 		JBrowse link
G ZNF416 zinc finger protein 416 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ZFP418 mRNA CTD PMID:28329830 NCBI chr19:57,571,566...57,578,911
Ensembl chr19:57,571,566...57,578,911 		JBrowse link
G ZNF487 zinc finger protein 487 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ZFP763 mRNA CTD PMID:28329830 NCBI chr10:43,436,848...43,523,894
Ensembl chr10:43,436,841...43,483,181 		JBrowse link
G ZNF608 zinc finger protein 608 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZFP608 mRNA CTD PMID:28329830 NCBI chr 5:124,636,915...124,748,824
Ensembl chr 5:124,636,913...124,748,807 		JBrowse link
G ZNF791 zinc finger protein 791 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZFP791 mRNA CTD PMID:28329830 NCBI chr19:12,610,920...12,633,834
Ensembl chr19:12,610,918...12,633,840 		JBrowse link
G ZRANB1 zinc finger RANBP2-type containing 1 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZRANB1 mRNA CTD PMID:28329830 NCBI chr10:124,916,894...124,988,189
Ensembl chr10:124,942,123...124,988,189 		JBrowse link
G ZSWIM4 zinc finger SWIM-type containing 4 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZSWIM4 mRNA CTD PMID:28329830 NCBI chr19:13,795,443...13,832,254
Ensembl chr19:13,795,443...13,832,254 		JBrowse link
G ZSWIM6 zinc finger SWIM-type containing 6 multiple interactions ISO [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZSWIM6 mRNA CTD PMID:28329830 NCBI chr 5:61,332,258...61,546,172
Ensembl chr 5:61,332,258...61,546,172 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 26050
    role 25966
      biological role 25945
        aetiopathogenetic role 24605
          carcinogenic agent 22905
            polycyclic arene 19677
              ortho- and peri-fused polycyclic arene 18732
                fluoranthene 765
                  7,10-bis(4-bromophenyl)-8,9-bis(4-octylphenyl)fluoranthene 0
                  7,10-bis(4-bromophenyl)-8,9-diphenylfluoranthene 0
                  7,10-bis(4-bromophenyl)-8-nonyl-9-octylfluoranthene 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 26050
    subatomic particle 26025
      composite particle 26025
        hadron 26025
          baryon 26025
            nucleon 26025
              atomic nucleus 26025
                atom 26025
                  main group element atom 25850
                    main group molecular entity 25850
                      s-block molecular entity 25171
                        hydrogen molecular entity 24769
                          hydrides 22979
                            organic hydride 21939
                              organic fundamental parent 21939
                                hydrocarbon 21366
                                  cyclic hydrocarbon 20002
                                    arene 19982
                                      polycyclic arene 19677
                                        ortho- and peri-fused polycyclic arene 18732
                                          fluoranthene 765
                                            7,10-bis(4-bromophenyl)-8,9-bis(4-octylphenyl)fluoranthene 0
                                            7,10-bis(4-bromophenyl)-8,9-diphenylfluoranthene 0
                                            7,10-bis(4-bromophenyl)-8-nonyl-9-octylfluoranthene 0
paths to the root